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SUMMARY
Leishmania parasites cause a wide spectrum of diseases Icnowii collectively as the 
leishmaniases. The three main forms of the disease are cutaneous (CL), 
mucocutaneous (MCL) and visceral (VL) leishmaniasis and particular species are 
usually associated with particular disease tropism. A better understanding of the 
mechanisms of disease would be beneficial in identifying potential drug targets and 
vaccine candidates. Genome projects for three species have now been completed: L. 
major (CL), L. infantum (VL) and L. braziliensis (MCL) and analysis of the highly 
syntenic genomes has revealed a small subset of species-specific genes that are 
hypothesised to contribute in some way to the tropism of that species. Four L. 
infantum-spQciûo genes were investigated in this project (LinJ28.0330, LinJ36.2750, 
LinJ20.1200 and LinJ36.2050). All foui’ genes, which are pseudogenes (or absent) in 
L. major and L. braziliensis, were found to be intact in L. donovani, another species 
that can cause VL. All genes except LinJ20.1200 are expressed in all three main life 
cycle stages, procyclic promastigote, metacyclic promastigote and amastigote. 
LinJ20.1200 appears to be promastigote-specific. LinJ36.2050 encodes a protein that 
is a putative orthologue of yeast SEC14. A  LinJ36.2050 null mutant (ASEC14) was 
generated. No defect in growth or in vitro infectivity of macrophages phenotype was 
observed with the ASEC14 cells. They were unable to establish cutaneous infection 
in mice and at the time of writing, it is not yet loiown if ASEC14 clones can be 
recovered from the spleens of hamsters at 4 months post-infection. Further detailed 
analysis is required to determine if the ASEC14 cells have a phenotype at the cellular 
level.
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CHAPTER 1 - INTRODUCTION
1.1 Leishmania and Leishmaniasis
Leishmaniasis represents a complex system of diseases with clinical and 
epidemiological diversity. It is caused by the kinetoplastid parasite Leishmania, and 
is endemic in 88 countries (22 in the “New World” (the Americas) and 66 in the 
“Old World” (Africa, Asia and southern Europe)). 16 of these are developed 
countries, 72 are developing countries (13 of them are among the least developed) 
(Desjeux, 1996). There are thirty known species of Leishmania and the majority are 
of them are human-infective (Banuls et al., 2007). They are grouped into either the 
Leishmania or Viannia subgenus, the latter being solely “New World”. The 
Leishmania subgenus is generally “Old World” with the exception of Leishmania 
(L.) mexicana complex (Table 1.1). Leishmania species can also be grouped 
according to the general disease forms associated with that species (see Section 
1.1.2).
1.1.1 Leishmania Life Cycle
Leishmaniasis is transmitted by blood-feeding female sand flies, as extracellular, 
flagellated promastigotes that differentiate into biologically distinct metacyclic forms 
prior to inoculation into the mammalian host. Transformation into proliferating 
intracellular, aflagellated amastigotes then occurs within the phagolysosome of host 
mononuclear phagocytes, which can facilitate the dissemination of parasites to 
different tissue site (Desjeux, 1996).
Parasites of the Leishmania species are obligate intra macrophage protozoan 
parasites with two life-cycle stages. Promastigotes are flagellated forms found in 
sandflies, and amastigotes are non-flagellated forms, which replicate in macrophage 
phagosomes in mammalian hosts (Lipoldova and Demant, 2006) (Figure 1.1).
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Figure 1.1: The life cycle of Leishmania (picture taken from the Centre for Disease 
Control, USA website).
1.1.2 Species Description and Disease Forms
Depending on which species is initiating the infection and on the immunological 
status of the host, Leishmania causes a wide spectrum of diseases. Clinical forms of 
leishmaniasis range from cutaneous (CL) and mucocutaneous (MCL) to diffuse 
cutaneous (DCL) and visceral (VL) and these are described in more detail below.
Three species have been identified as causing the visceral form of the disease and 
several other distinct Leishmania species cause the cutaneous and mucocutaneous 
forms (McMahon-Pratt and Alexander, 2004). More than 90% of the VL cases in the 
world are reported in Bangladesh, Brazil, India and Sudan and more than 90% of the 
CL cases occur in Afghanistan, Iran, Saudi Arabia and Syrian Arab Republic in the 
Old World and Brazil and Peru in the New World. This places an estimated 350 
million people at risk (Desjeux, 1996).
Table 1.1: Different Leishmania species and associated diseases
Disease form New World Species Old World Species
Cutaneous L. (L.) mexicana complex
L. (L.) mexicana 
L. (L.) amazonensis 
L. (L.) pifanoi 
L. (L.) venezuelensis
L. (Viannia) subgenus
L. (V.) braziliensis 
L. (V.) peruviana 
L. (V.) lansoni 
L (Vj naijf 
L (v .)  panamensis 
L. (V.) guyanensis
L (L) major complex
L. (L) major 
L. (L) tropica 
L (L.) aethiopica
Mucocutaneous L. (V.) braziliensis
Diffuse cutaneous L (l )  amazonensis 
L (L) pifanoi
L (L.) aethiopica
Visceral
L. (L) chagasi" '^ L. (l.) donovani complex
L. (L.) infantum 
L. (L.) donovani
* - Note that L. (L.) chagasi is widely considered to be a synonym o f  L. (L.) infantum as no evidence o f  ancient lineage 
can be found (Mauricio et al., 2000). Rather it is held that the species has been introduced from dogs/rodents by 
European settlers.
1.1.3 Visceral Leishmaniasis
Also known as kala-azar, this form of the disease is caused by species of the Z. 
donovani complex and is the most severe form. The disease is characterised by 
fever, enlargement of the spleen (splenomegaly) and liver (hepatomegaly), anaemia 
and severe weight loss. This form of the disease is usually fatal if left untreated. 
Serious epidemics of VL have occurred in India and East Africa in recent years, 
while the number of cases of VL is currently increasing in Brazil (Desjeux, 1996).
Figure 1.2: Sudanese woman with visceral Leishmaniasis (Taken from Herwaldt 
(1999)).
1.1.4 Cutaneous Leishmaniasis
Cutaneous Leishmaniasis in the Old World is due to Z. major which produces self- 
healing lesions as the parasites remain at the sites of infection, the sand fly bite 
(Figure 1.3). The mechanisms involved in cutaneous disease caused by for example, 
Z. major and Z. mexicana, are limited. Cutaneous infection can remain sub-clinical 
or become clinically apparent after a variable incubation period that averages several 
weeks. Lesions can form at the site of infection and are usually self-healing 
(Herwaldt, 1999).
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Figure 1.3: Patient suffering from cutaneous leishmaniasis (Taken from Herwaldt 
(1999)).
1.1.5 Mucocutaneous Leishmaniasis
Mucocutaneous Leishmaniasis is caused by parasites of the Viannia subgenus, for 
example L. braziliensis. Clinical symptoms can indicate extensive destruction of the 
oral-nasal and pharyngeal cavities resulting in severe disfigurement (Figure 1.4). 
Typically, mucosal disease becomes evident because of chronic nasal symptoms, in 
context of a hyperactive immune response. The disease is not normally self-limiting 
and requires treatment, however, diagnosis is difficult, even when clinically active. 
MCL is more difficult to treat than CL. Currently, the best treatment options are 
pentavalent antimony drugs (Herwaldt, 1999).
Figure 1.4: Mucocutaneous Leishmaniasis sufferer with perforation of the nasal 
septum. (Taken from Herwaldt (1999)).
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1.1.6 Factors that May Give Rise to Different Disease Tropism
The different disease tropisms caused by different Leishmania species are thought to 
be determined by a number of factors (McMahon-Pratt and Alexander, 2004):
• Immune status of the host
• Genetic differences between Leishmania species
The extent to which these parasites are able to resist the host’s innate and acquired 
immunity will directly contribute to their establishment in the host and consequently 
to disease severity (Campos-Ponce et al., 2005). For example, although species of 
the L. donovani complex generally cause visceral disease, there have been reports of 
cases of cutaneous infection by these species (McMahon-Pratt and Alexander, 2004; 
Siriwardana et al., 2007).
1.2 Modes of Infection
1.2.1 Host-Parasite Interaction
The macrophage is the immune-effector cell that, upon activation, is normally able to 
kill foreign pathogens. This cell, however, is the main mammalian host cell for all 
Leishmania.
1.2.1.1 Uptake by Macrophages (Phagocytosis)
Upon first exposure to the mammalian host during sand fly feeding, Leishmania 
promastigotes encounter host macrophages whieh can bind to (via Leishmania 
surface molecules -  see Section 1.2.1.2) and internalise the parasite cells in the same 
way other pathogens are taken up. Leishmania spp are remarkably resistant to 
macrophages and can survive, differentiate and proliferate in the parasitophorous 
vacuole of the macrophage. Other host eells can take up Leishmania promastigotes.
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also (see Section 1,2.1.4), but the macrophage is the cell type in which the parasites 
can differentiate and proliferate within the mammalian host.
1.2.1.2 Surface Molecules & Parasite Interaction with Host Cells 
There are two major families of promastigote surface molecules: -
• GP63:- The major surface metallopeptidase, found in large numbers on the 
promastigote surface, but not the amastigote surface
• Phosphoglycans: - Includes glycolipids such as lipophosphoglycan (LPG), 
phosphoglycosylated proteins and proteophosphoglycans (Handman and 
Bullen, 2002).
These have been proposed to be required for binding to macrophages, the initial step 
for establishment of infection (Kelleher et al., 1995). They have also been 
implicated in the resistance of promastigotes to complement-mediated lysis prior to 
uptake by macrophages (Ilgoutz and McConville, 2001).
1.2.1.3 Amastigote Invasion of Macrophages
L. major LPG has been found to be involved in initial survival of promastigotes in 
the host prior to and following cell invasion by promastigotes but are less important 
to amastigotes, where LPGs are strongly downregulated (Spath et al., 2003; Ilgoutz 
and McConville, 2001). It is believed that infected macrophages in mammalian hosts 
eventually rupture, releasing amastigotes which then go on to infect more 
macrophages, however, little is known about the mechanism and molecules involved 
in amastigote invasion and survival in these cells (Handman and Bullen, 2002).
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1.2.1.4 Uptake by Other Cells (Trojan Horses)
As already discussed the mammalian stage amastigotes exist intracellularly, and the 
prefen'ed host cell is the macrophage. Leishmania promastigotes are quickly killed in 
the extracellular tissue environment and can only suivive if they enter phagocytic 
cells. Often, polymorphonuclear neutrophil (PMN) granulocytes, rather than 
macrophages are the first cells Leishmania will encounter (van Zandbergen et al., 
2004). Z. major has been shown to be capable of entering and surviving as 
promastigotes within PMN. This causes apoptosis of the PMN, which is then taken 
up by macrophages, together with the surviving Z. major. Thus, the parasite appears 
to be using the PMN as an intermediate host cell for up to 42 hours post-infection, 
prior to uptake of infected PMN by macrophages (van Zandbergen et al., 2004).
1.3 Genomics
1.3.1 Genome Projects
The Welleome Trust Sanger Institute has sequenced the Z. major genome to 
completion and more than 8000 genes have been annotated in the -33.6Mb genome 
(Ivens et al., 2005). The genomes of Z. infantum and Z. braziliensis were the next 
genome projects to be completed (Peacock et al., 2007) and Z. mexicana will be the 
fourth, although this project is in the early stages at the time of wiiting 
(http://www.sanger.ac.uk/sequencing/Leishmania/mexicana/ ).
The number of chiomosomes and genes in each species is summarised in Table 1.2. 
Z. braziliensis has 35 chiomosomes compared with 36 in both Z. major and Z. 
infantum and this is due to the apparent fusion of chiomosomes 20 and 34 in Z. 
braziliensis (Peacock et al., 2007).
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Table 1.2: Genomes of three Leishmania species in summary
Leishmania species L. infantum L. major L. braziliensis
Number of
chromosomes 36 36 35
Number of genes 8154 8298 8153
1.3.1.1 Comparative Gene Content Analysis of Leishmania
The organisation of the genes in all three species of Leishmania sequenced to date 
has shown to have a high degree of synteny i.e. the positions of genes relative to one 
another is highly conserved in all species studied (Peacock et al., 2007). An example 
of this synteny is shown in Figure 1.5.
380000 385lOO lOOOO 395000
260'000j5000 70000
□ CD
270000 275000 280000 285000
L. infantum
L  major
L. braziliensis
Figure 1.5: An example of the high degree of synteny between the three species of 
Leishmania with genomes sequenced to date. The example shown is the genomic 
locus of a putative RNA Binding Protein (LinJ32.1150) (green arrow) and the genes 
surrounding it.
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This has made it possible to directly compare the genes found in each species and 
identifies those that are specific to each species. Peacock et al (2007) have reported 
that the number of species-specific genes is remarkably small (Figure 1.6).
L. n iay b /-
Figure 1.6: Venn Diagram showing the number of genes that are unique to each 
species as well as those genes that are common to two or more species. The majority 
of these genes are hypothetical.
Despite the vastly different disease forms, a surprisingly small number of genes have 
been found to be unique to each species: 26 L. m/hw/ww-specific genes, 5 L. major- 
specific genes, and 49 L. braziliensis-specific genes (Figure 1.6). The hypothesis 
underlying the program of study, of which this project is a part, is that at least some 
of these genes will contribute to the molecular mechanisms giving rise to the disease 
tropism of a particular species.
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1.3.2 Genes Differentially Distributed Between Three Leishmania Species
To date the multi-copy A2 gene (LinJ22.0680) is the only gene shown to be involved 
in L. donovani visceral disease tropism (Zhang and Matlashewski, 1997; Zhang and 
Matlashewski, 2001; Zhang et al., 2003). The gene is not expressed in L. major and 
detailed characterisation of the L. donovani and L. major A2 loci revealed that the 
multiple amino acid repeat sequences found in the L. donovani protein are absent 
from L. major; the gene is truncated containing only a single amino acid repeat 
region. The A2 gene has been shown to be necessary for survival of L. donovani in 
visceral organs and loss of several copies of the A2 array results in compromised 
BALB/c mouse infections (Zhang and Matlashewski, 2001). Interestingly, 
heterologous expression of the L. donovani A2 gene in L. major prevented the 
cutaneous infection being established in both resistant and susceptible mice. This 
indicates that disease tropism can be influenced by just a single gene. The full 
mechanism of visceralisation will almost certainly require additional genes. The 
genes that are unique to L. infantum are listed in Table 1.3.
17
Table 1.3: The unique genes of L. infantum (Peacock et al., 2007). The genes that 
will be examined in this study are highlighted in red.
Product L. infantum Product L. infantum
Hypothetical protein LinJ02.0670 Multidrug resistance protein LinJ30.1840
Hypothetical protein LinJ08.0140 n-acyl-l-amino acid 
amidohydrolase
LinJ31.1490
Tuzin LinJ08.0750 Hypothetical protein LinJ31.2630
Hypothetical protein LinJlO.1430 p-nitrophenyl-phosphatase LinJ31.3030
Phosphatidylinositol 3-kinase LinJ 14.0020 Hypothetical protein LinJ31.3160
Hypothetical protein LinJl 5.0890 Hypothetical protein LinJ32.1900
Hypothetical protein LinJ20.1210 Hypothetical protein LinJ33.2710
Methylenetrahydrofolate
dehydrogenase
LinJ22.0330 Hypothetical protein LinJ34.3170
Hypothetical protein LinJ22.0410 Phosphatidylinositol/ 
phosphatidylcholine SEC14 
cytosolic factor
Lin,I36.2050
Hypothetical protein LinJ22.0680 Hypothetical protein LinJ36.2060
Hypothetical protein LinJ24.1430 Glyceraldehyde 3-phosphate LinJ36.4900
Glutathionyl-spermidine
synthase
LinJ25.2500 Hypothetical protein LinJ36.2750
Hypothetical protein LinJ28.0330 Endo-l,4-P-Xylanase Lin.l20.l200
1.3.3. L. /«ya/f/M/M-Specific Genes of Interest
There are four specific genes of interest that were analysed during this project, they
are:-
• LinJ28.0330 -  encodes a hypothetical protein
• LinJ36.2750 -  encodes a hypothetical protein
• LinJ20.1200 -  encodes a putative endo-1,4-p-xylanase precursor protein
• LinJ36.2050 -  encodes putative SEC 14 cytosolic factor
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These four genes were chosen from the 27 unique genes in L  infantum for further 
study in this project. The two hypothetical genes were selected at random (although 
LinJ36.2750 was chosen because it has a homologous domain (TRF4) that may 
provide a handle for further study (see Section 1.3.3.2). LinJ36.2050 was selected as 
it is potentially involved in trafficking, a process that could influence host-parasite 
interactions and therefore potentially, disease tropism (see Section 1.3.3.4). 
LinJ20.1200 was selected as a poor candidate for involvement in disease tropism that 
could quickly be eliminated from the overall study (see Section 1.3.3.3).
1.3.3.l.LinJ28.0330
This gene encodes a hypothetical protein and according to GeneDB it is intact in L. 
infantum, whereas the gene in the equivalent position in both L. major and L. 
braziliensis contains ffameshifts and/or introduced stop codons (Figure 1.7). 
Presumably, the latter two species, by contrast with L. infantum, have lost a 
biologically relevant function for this protein, if indeed it is expressed in L. infantum. 
There are no recognisable domains in the primary amino acid sequence to yield any 
clues to the potential role of this protein.
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Figure 1.7; LinJ28.0330 Locus of chromosome 28 (in all three species) showing the 
pseudogene orthologues (grey) in both L. major and L. braziliensis. This also 
highlights the high degree of synteny of each species.
1.3.3.2. LinJ36.2750
This gene also encodes a hypothetical protein and is present in L. infantum but is 
apparently missing from both L. major and L. braziliensis (Figure 1.8). Similarly to 
LinJ28.0330, if LinJ36.2750 is expressed in L. infantum, then the other species are 
likely to have lost a biological requirement for the gene and it has undergone 
mutation such that the gene is no longer intact.
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Figure 1.8: LinJ36.2750 locus on chromosome 36 in L. infantum and L. major and 
chromosome 35 of I. braziliensis. This schematic demonstrates that the gene is 
apparently missing from both L. major and L. braziliensis.
On closer inspection, remnants of the gene can be identified in the gap region where 
the gene ought to be in L. major. There are also remnants of the gene in L. 
braziliensis but these are even more divergent than the L  major sequence suggesting 
that the gene was lost long ago in evolutionary terms.
The encoded protein, although hypothetical, contains a domain that has homology to 
TRF4, a domain related to the TRJF4 proteins of the yeast Saccharomyces cerevisiae. 
These form part of a nuclear poly adénylation complex that can mediate the 
polyadenylation and degradation of ribosomal RNA (rRNA) and/or small nucleolar 
RNA (snoRNA) precursors (LaCava et al., 2005). Reciprocal BLAST analysis with 
the S. cerevisiae TRF4 amino acid sequence (GeneDB Omniblast against predicted 
proteins in L. infantum, L. major and L. braziliensis) has revealed several genes 
encoding TRF4 domains. LinJ36.2750 was the third highest hit.
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1.3.33. Endo-l,4-(3“Xylanase
This gene encodes a protein with predicted function based on homology with other 
characterised proteins and is present in L. infantum. It appears to be a pseudogene in 
L. major and L. braziliensis (Figure 1.9). Xylanases are enzymes that degrade the 
polysaccharide xylan, a major component of some plant cell walls. Xylanases are 
also present in fungi for the degradation of plant matter as part of the plant 
pathogenesis mechanism or to assimilate usable nutrients (Brito et ah, 2006). Some 
species of sand flies (e.g. Phlebotomus papatasi) are known to consume plant matter 
between blood meals for sustenance (Schlein and Jacobson, 2002) and one of the 
major components of the cell walls of one species of plant, Proposis far eta, 
consumed by these sand flies is xylan (Schlein and Jacobson, 1995; Pasiecznik et al., 
2001), One might therefore predict that this L. infantum-s^eeiûe enzyme will be 
preferentially expressed in the promastigote (sand fly) life-cycle stage, because it is 
dming this stage that the cells are most likely to encounter plant material, in the 
midgut of the sandfly.
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Figure 1.9: The genomic locus of chromosome 20 containing LinJ20.1200 (endo- 
1,4-p-xylanase precursor) in L. infantum compared with the locus in L. major and L. 
braziliensis. The gene has become a pseudogene in the latter two species but is 
intact in L. infantum.
1.3.3.4, LinJ36.2050 - SEC 14 Cytosolic Factor
LinJ36.2050 has been annotated on GeneDB as encoding SEC 14 cytosolic factor. 
This gene is not annotated in L. major and only remnants of the gene have been 
identified in T. braziliensis (figuvQ 1.10).
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Figure 1.10: The genomic locus of the SEC 14 gene in three species o f Leishmania. 
The gene is apparently intact in L. infantum but is “missing” from L. major and 
remnants of the gene have been identified in L. braziliensis.
The annotation of the gene in GeneDB as SEC 14 Cytosolic Factor indicates that it is 
a possible orthologue of the SEC 14 gene of the budding yeast Saccharomyces 
cerevisiae. The encoded protein (Secl4p) is the main phosphatidylinositol transfer 
protein (PITP) in this organism and plays an essential role in protein transport from 
the trans-Golgi network (TGN) to the plasma membrane. This was originally 
demonstrated in yeast temperature sensitive mutants that exhibit a block in secretory 
vesicle formation at the TGN at non-permissive temperatures (Bankaitis et al., 1989). 
To date over 500 SEC 14-like proteins all within eukaryotic species have been 
identified with roles in processes such as vesicle trafficking and phospholipid 
metabolism (Mousley et al., 2007; Phillips et al., 2006). At the most basic level of 
activity, these PITPs can extract a single phosphatidylinositol molecule (PI) from 
membrane and transfer it to another by an unknown mechanism (Figure 1.11). Yeast 
Secl4p can also extract and transfer phosphatidylcholine (PC) molecules (Hsuan and 
Cockcroft, 2001). Five other SEC 14 homologues (Sfhl-5) have been identified in
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yeast and most have retained their ability to transfer PI but not PC (Phillips et al., 
2006).
The L. infantum SEC 14 gene encodes a protein with approximately 16% identity and 
26% similarity to yeast Secl4p. If this protein is involved in the secretory pathway 
as it is in yeast, then it could potentially influence molecules that are either secreted 
or found on the surface of the parasite and so contribute to host-parasite interactions.
Pl-enriched 
donor membrane Pl-pooracceptor membrane
PITP loaded with PC
&
PITP loaded with PI
(Endoplasmic reticulum) (Plasm a membrane)
Figure 1.11; The phosphatidylinositol/phosphatidylcholine transfer activity of 
PITPs such as yeast Secl4p. Taken from (Hsuan and Cockcroft, 2001).
1.3.4 Project Aim
The aim of this project is to test the hypothesis that some of the L. infantum-spQcifxc. 
genes contribute to the disease tropism of that species. Four of the 26 L. infantum- 
specific genes (Figure 1.6) were selected to study in more detail. These are 
highlighted in red in Table 1.3.
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CHAPTER 2 -  MATERIALS AND METHODS
2.1 Molecular Methods
2.1.1 Bacterial Strains
Two strains of bacteria were used during this study as described in Table 2.1.
Table 2.1: Bacterial strains
, Strain Uses Reference
XL 1-Blue cells Supercompetent cells for high- 
effrciency transformation
Stratagene
XLIO-Gold Ultracompetent cells for high- 
efficiency transformation
Stratagene
2.1.2 Bacterial Culture Methods
Approximately 10ml of Luria-Bertani (LB) broth containing appropriate antibiotics 
in a sterile glass test tube was inoculated with a single colony using a sterilised 
toothpick. Cultures were grown overnight at 37^C in a rotary incubator. Where 
medium-scale plasmid preparation was required, l-2ml of an overnight culture 
(grown from a single colony) was used to inoculate 25-50ml of fresh LB broth.
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2.1.3 Long Term Storage of Bacteria
Cells were plated on Luria-Bertani (LB)-agar plates with appropriate antibiotics and 
incubated overnight at 37°C. A single colony was used to inoculate 5ml of LB broth 
with antibiotics and cells were grown overnight at 37^C. LOml of the overnight 
culture was mixed with LOml 2% peptone, 40% glycerol and cells were stored at 
~80"C.
2.1.4 Preparation of Competent Bacteria Using CaCL^
A single colony of XLl E. coli strain was used to inoculate a 5ml LB plus 
appropriate antibiotic and shake overnight at 37°C. 25ml LB plus antibiotic was 
inoculated with overnight culture. Cells were centrifuged for 10 minutes at 4°C. 
Then pellet was suspended in 0.5 original volume cold, sterile 50 mM CaCb 
(12.5ml) and resuspended gently by pipetting up and down a few times with a wide 
bore pipet. Cells were left on ice for 30 minutes and centrifuged as before at 4°C. 
The pellet was resuspended in 0.1 original volume of CaCb and split into 50-200pl 
aliquots. 50pi was used for each transformation.
2.1.5 Plasmid Purification
Several different kits were used to purify plasmid depending on requirements;
® Qiagen Qiaprep Spin Miniprep Kit was used for small scale plasmid 
purification.
• Qiagen Hispeed Plasmid Midi Kit was used for larger-scale plasmid 
purification.
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The quality and quantity of the purified DNA was assessed spectrophotometrically 
by recording absorbance at 260nm and 280mn wavelength.
DNA concentration was calculated as follows: A260 x 50 x dilution factor (generally 
50 fold dilutions of mini-prep DNA so the concentration in ng/pl would be 
calculated by A260 x 50 x 50.
2.1.6 Polymerase Chain Reaction (PCR)
PCR was used to amplify DNA fragments for subsequent cloning and analysis or for 
the colony-screening of transformed bacteria. For general PCR analysis a 20pi 
reaction was set up with the non-proofreading Taq DNA Polymerase (NEB) as 
shown in the Table 2.2.
Table 2.2: Contents of a Standard PCR Reaction
Component Volume/ 20pl reaction
lOx PCR mix (See 
Section 2.4) 2pl
Primer A (O.lpg/ml) 2pl
Primer B (0.1 pg/ml) 2pl
Template DNA 0.5pl
MilliQ H2O 13pl
Taq DNA Poylmerase 0.5pl
Where high sequence fidelity was required, the polymerase was replaced with one of 
several proof-reading DNA polymerases available (Table 2.3) according to
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manufacturer’s instructions. Wherever possible, the reaction buffer supplied with the 
proof-reading enzyme was used instead of lOx PCR Buffer
Table 2.3: Proof-reading DNA Polymerases Used in this Study
Enzyme Manufacturer
Pfu Turbo Stratagene
Deep Vent NEB
Phusion NEB (Finnzymes)
P&50 Invitrogen
Products generated by high-fidelity PCR that were to be cloned into T-vectors such 
as pGEM-T Easy (Promega) or pCR2.1 TOPO (Invitrogen) required the addition of 
A-overhangs. This was accomplished by adding 0.5-1.0pl of Taq DNA Polymerase 
(NEB) directly to the PCR reactions at the end of the final cycle and incubating for a 
further 10-20 minutes at 12°C prior to electrophoresis and gel-extraction.
2.1.7 Restriction Digests
Restriction enzymes were obtained from New England Biolabs and used according to 
manufacturer’s instructions with the buffers supplied/recommended. Generally, 1- 
5pg of plasmid DNA was digested in a single 20pl reaction for 1-2 hours at 37®C. 
Larger-scale digests were scaled up in volume and/or digest-time.
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2.1.8 DNA Gel Electrophoresis
Gels were prepared by dissolving 0.8-1.2 %( w/v) agarose in 0.5 x TBE buffer. Prior 
to pouring the gels, 2pi of SYBR Safe DNA Gel Stain (Invitrogen) was added per 
100ml of molten gel. DNA samples were mixed with 10 x DNA loading buffer and 
were electrophoresed at 60-170V until the dye in the loading buffer had migrated 
approximately two thirds of the length of the gel. Gels were viewed under UV 
illumination and images obtained by using a Bio-Rad gel documentation system. If 
required, DNA bands were cut from the gels for puiification and subsequent cloning.
2.1.9 Purification of DNA from Agarose Gels
DNA cut from agarose gels was purified using the Qiaquick Gel Extraction Kit 
(Qiagen) according to manufacturer’s instructions.
2.1.10 Phosphatase Treatment of Digested Plasmids
Plasmids digested with a single restriction enzyme were treated with calf intestinal 
alkaline phosphatase or CIAP (NEB) prior to ligation. This removes the 5’ tenninal 
phosphate in order to reduce the chances of plasmid re-ligation, rather than ligation 
with the added DNA fragment of interest. This was done as follows:
Plasmid digests were incubated at 65°C for 20 minutes to heat-inactivate the 
restriction enzymes (where possible). Ipl of CIAP was added directly to the heat- 
inactivated restriction digest mix and incubated at 37°C for 30-60 minutes. The 
digests were run out on DNA agarose gels and appropriate bands were excised form 
the gel for subsequent use.
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2.1.11 DNA Ligation
Ligation of DNA fragments with available T vectors such as pCR2.1 TOPO TA 
(Invitrogen) and pGEM-T or pGEM-T Easy (Promega) was earned out according to 
manufactui'er’s instructions. Other ligations were carried out by adding various 
volumes of plasmid and insert in a total volume of lOpl containing Ix T4 DNA 
ligase buffer and 0.5pi T4 DNA ligase (New England Biolabs). Reactions were 
either incubated at room temperature for 30-120 minutes or overnight at 16^C (4°C 
forpGEM-T cloning).
2.1.12 Transformation of Competent Bacteria
Chemically competent cells made from the XLl-blue strain by the CaCli method 
were used for routine transformations. For lower efficiency ligations, commercially 
available XLl-Blue Supercompetent Cells and XL 10-Gold Ultracompetent cells 
(Stratagene) were used. Cells were mixed with 5pi of ligation reaction and 
transformed by heat shock for 30 seconds (chemically-competent bacteria) or 
according to manufacturer’s protocol for cells obtained from Stratagene.
2.1.13 DNA Sequencing
The DNA Sequencing Facility at the University of Dundee was used for all sequence 
analysis (http://www.dnaseq.co.uk). Plasmid concentration was assessed by 
A260/A280 absorbance. 250-300ng of high-quality plasmid DNA in 15pl was required 
per sequencing reaction. “Standard” primers such as M l3 Forward (-20), M l3 
Reverse, T7, T3 and SP6 were provided by the DNA Sequencing Facility. Gene- 
specific primers were prepared by diluting primers to 3.2pmoles/pl in water and
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these were sent to the DNA Sequencing Facility along with the plasmids to be 
sequenced.
Sequences were analysed using Vector-NTI Advance 10 software package 
(Invitrogen).
2.2 Leishmania infantum Methods
2.2.1 Cell Lines
The following Leishmania cell lines were used in this study (Table 2.4).
Table 2.4: Leishmania Species and Strains
Species Strain Notes
L. infantum JPCM5 Genome project strain
L. donovani BPK206/0 (Clone 
10)
Field Isolate from bone marrow 
of Nepalese VL patient, 2003. 
Provided by Lesley McCaig, 
University of Glasgow
2.2.2 Leishmania Tissue Culture
L. infantum and L. donovani promastigotes were grown at 25°C in HOMEM medium 
(Gibco BRL) supplemented with 10% heat-inactivated foetal calf serum (FCS) and 
1% Penicillin-Streptomycin (Sigma). Cells were inoculated into fresh medium at 
approximately 5x10^ cells/ml and were sub-passaged into fresh medium when 
cultures reached late-log or early stationary phase.
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2.2.2.1 Leishmania Cell Counts
Cells were diluted and fixed by adding lOpl of cells to lOpl of PBS/ 1% 
formaldehyde. 10pi of fixed cells were loaded into each chamber of an improved 
Neubauer haemocytometer and counted under microscopy.
2 2 2 2  Harvesting Leishmania
Cells in culture were generally harvested by centrifugation at 1200xg for 5 minutes 
followed by two washes in PBS (both followed by centrifugation as before). Cells 
were used immediately or frozen at -80^C. For RNA extraction, 1 x 10  ^ cells were 
resuspended in 1ml of Trizol (Invitrogen) immediately following the first 
centrifugation (i.e. before any PBS washes).
2.2.2.3 Haiwesting L. infantum Amastigotes for RNA Collection
To purify amastigotes from infected hamsters, the buffers and the sephadex were
prepared and swelled overnight at 4“C before the purification.
Table 2.5: Component for purification (PSGEMKA)
Component Volume
NaCl 15.75g
Glucose 15g
EDTA 0.285g
MgCa.ôHiO 3.04g
KCl l . l lg
Albumin (Bovine) 0.30g
Buffer X (0.02M Na2HP04.2H2 0 ) 108ml
Buffer Y (0.02M NaH2P04.2H2 0 ) 34.5ml
H2O 1357ml
2.5g of Sephadex was swelled overnight in 100ml of PSGEMKA buffer. Hamster 
spleen was removed using standard asceptic techniques. The spleen and was cut into
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small fragments which were broken up in the tissue grinder with the gradual addition 
of 400mls of PSGEMKA until no solid pieces of lesion remained. lOOpl of crude 
extract was removed for counting amastigotes. 50mg of Saponin was resuspended in 
5-10 ml PSGEMKA and was mixed with the 400ml crude amastigote suspension. 
The suspension was split in to 8x50ml falcon tubes and centrifuged for 10 minutes at 
3.400rpm in a swing bucket rotor (approximately 1500xg). Supernatant was 
removed with 25ml pipette and the pellets washed two more times and resuspended 
in a final volume of 100ml. lOOpl of this suspension was collected for counting 
(pre-column). The amastigote purification column was prepared and PSGEMKA 
used to remove air bubbles before the Sephadex solution was poured in the column. 
The column was washed with 100ml PSGEMKA. Then the amastigote suspension 
was added to the column. The amastigotes flow through the column, while the tissue 
debris and host cells remain in the column. 50ml of PSGEMKA was added to flush 
amastigotes thiough and the flow thi'ough was collected. lOOpl of the flow through 
was used to count cell numbers (post column). Purified amastigotes were 
centrifuged and washed twice with PBS and resuspended at 5 x 10  ^ cells per ml of 
Trizol.
2.2.3 Long Term Storage of X. infantum Cell Lines
0.5ml of a log phase culture was diluted with an equal volume of fresh medium 
containing 10% DMSO. Samples were stored overnight at -20°C and stored 
overnight at -80 and then transferred to liquid nitrogen for long-term storage.
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2.2.4 Transfection ofX. infantum
Cells were harvested and washed before being resuspended at 2x10^ cells/ml in 
cytomix (Reference Ngo etal 1998, Robinson and Beverley 2003) and kept on ice. 
1x10^ cells in 500pl were transfeiTed to a pre-chilled 0.4cm electroporation cuvette. 
Target DNA (either an episome or a linearised knockout cassette) or water (control 
transfection) was added to each cuvette and cells were electroporated with 2 pulses, 
10 seconds apart (1.50kV and 25pF capacitance) in a Gene Puiser II Electroporation 
System (Bio-Rad). Cells were allowed to recover on ice for 10 minutes before being 
transferred to 10ml fresh medium and immediately split into 2 flasks (5ml each). 
Control transfection cultures were not split in this way but remained in 10ml of 
medium. Flasks were incubated overnight at 25*^ C overnight. Cells were then plated 
on 96 well plates by serial dilution in fresh medium containing the appropriate 
antibiotics (see Table 2.6).
To obtain clones, 4ml of each overnight culture was diluted into 20ml HOMEM/FCS 
+ antibiotics (Dilution 1). 2ml of Dilution 1 was added to 22ml of HOMEM/FCS + 
antibiotics (Dilution 2) and 2ml of Dilution 2 was then added to 22ml of 
HOMEM/FCS + antibiotics (Dilution 3). 200pi of Dilution 1 was added to every 
well on a 96 well plate. The same was done for Dilutions 2 and 3, giving 3 plates for 
each overnight culture. To the remaining 1ml in each overnight flask, 9ml of fresh 
HOMEM/FCS + antibiotics was added -  a transfected population. Cells growing up 
in this cultuie are unlikely to be clonal so further serial dilution is generally required. 
For the control (no DNA) transfections, 1ml of these cells were added to 9ml of fresh 
HOMEM/FCS + antibiotics. This dilution was necessary to prevent the cells 
reaching stationary phase before antibiotic selection was complete.
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2.2.4.1 Antibiotics Used for Selection oiLeishmania Transfectants. 
The antibiotics used in this study are detailed in Table 2.6.
Table 2.6: Antibiotics Used for Selection of Leishmania infantum
Resistance Marker 
Gene
Antibiotic Reference
SAT Nourseothricin Hans Knoll Inst., 
Germany
BLE Phleomycin Zeocin (Invitrogen)
NEO G418 (analogue of 
neomycin)
Merck
2.3 DNA Manipulation
2.3.1 Isolation of Genomic DNA from LAnfantum
Genomic DNA was generally isolated from 10ml of late log phase or stationary 
phase cultures using the DNEasy Blood and Tissue Kit (Qiagen) according to 
manufacturer’s protocol for cultured animal cells. For larger scale DNA preparation, 
larger volumes or cells were used with multiple DNEasy preps and the isolated 
genomic DNA was pooled.
2.3.2 Precipitation of DNA
DNA precipitation was used to concentrate DNA samples that were too dilute for 
practical analysis or experimentation. Generally, isopropanol precipitation was used 
as follows: 0.7 volumes of isopropanol was added to DNA and incubated at room 
temperature for 15 minutes. DNA was pelleted by centrifugation at 12,000xg for 15 
minutes. Pellets were washed in 70% ethanol and centrifuged again. Pellets were
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allowed to air-dry for 5 minutes before resuspending in MilliQ water or appropriate 
buffer.
Concentration and quality of DNA was assessed by spectrophotometer (A260/A280) 
and/or by DNA gel electrophoresis.
2.3.3 Southern Blotting of DNA Fragments
3-5pg genomic DNA was digested overnight with appropriate restriction enzymes 
and digested products were electrophoresed on a 0.7% agarose gel. The gel was 
incubated with 0.3 pg/ml ethidium bromide and analysed under UV to allow a scale 
image of the gel to be obtained. The gel was washed in distilled water for a few 
minutes before incubation for 30 minutes in depurination solution. The gel was then 
rinsed in distilled water and incubated for 30 minutes in dénaturation solution. After 
another wash in water the gel washed for 10 minutes in 20xSSC .DNA was 
transferred to nylon membrane overnight. The transferred DNA fragment on nylon 
membrane was attached to the membrane by using UV for 20 seconds. The 
membrane was added to 5ml of Chui'ch-Gilbert solution and incubated at 100°C. The 
probe was radiolabeled and purified by using the Megaprime DNA Labeling Kit 
(Amersham). The probe was added to the Church-Gilbert solution and Southern blot 
membrane in the hybridisation tube and incubated overnight at 65°C. The blot was 
washed 3 times for 15 minutes in 2 x SSC/0.1% SDS followed by 3 x 15 minutes 
washes with 0.1 x SSC/0.1%SDS. The membrane was exposed to autoradiography 
film for a few days and developed.
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2.3.4 FACS Analysis to Assess DNA Content
1ml of log phase promastigotes were pelleted by slow-speed centrifugation (lOOOxg 
for 5 minutes) and resuspended in 70% methanol/PBS overnight to fix. Fixed cells 
were washed with PBS followed by slow-speed centrifugation. Cells were 
resuspended in 1ml of PBS containing 10pg/ml propidium iodide (Sigma-Aldrich) 
and 10pg/ml RNase A and incubated at 37®C for 1 houi' protected from the light. 
Cells were then immediately analysed in FACScalibur System (BD Biosciences) for 
DNA content.
2.4 Buffers and Reagents
lOx PCR M ix: 45mM Tris-HCl (pH8.8), llm M  Ammonium phosphate, 4.5 inM 
MgCE, 6.7mM p-mercaptoethanol, 4.4mM EDTA (pHB.O), ImM dATP, ImM dCTP, 
ImM dGTP, ImM dTTP and 113pg/ml BSA. Store at -20°C.
Ampicillin: Stock solution is lOOmg/ml in distilled water. Storage at -20C. Used at 
1 pg/ml.
Church-Gilbert’s solution: 340mM Na2HP04, 158mM NaH2p 04, 240Min SDS, 
ImM EDTA .Heated gently to solubilise components. Store at room temperature.
Cytomix: 120mM KC12, 0.15mM CaC12, lOmM K2HP04, 25mM HEPES, 2mM 
EDTA and MgC12; pH 7.6
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DNA loading buffer (lOx): 25% Ficoll, 0.42% bromophenol blue. Store at room 
temperature.
Depurination solution: 0.250M HCl. Store at room temperatme.
Dénaturation solution: 1.5MNaCl, O.SMNaOH. Store at room temperatm'e.
Ethidium bromide: lOmg/ml stock solution in distilled water. Store at room 
temperature.
Luria-Bertani (LB) broth: LB broth plus 0.8% (w/v) agar. Autoclaved to sterilise 
and store at room temperature.
Neutralisation solution: 1.5M NaCl, 0.5 M Tris-HCl pH7.0, store at room 
temperature.
PBS: lOmM phosphate buffer, 2.7Mm KCl, 137Mm NaCl, Ph 7.4. Autoclaved when 
required for tissue culture. Store at room temperature.
SSC (20 x): 3M NaCl, 0.3M Tri-sodium citrate pH7.0. Store at room temperature.
T B E  (lO x): 0.9M Tris-HCl, 0.9M boric acid, 25 mM EDTA. Store at room 
temperature.
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2.5 Oligos Used in This Study
All oligos used in this study are listed in Table 2.7.
Table 2.7: Details of all oligos used in this study.
Prim er S é q u e n c e Description
OL1984 GCACCCGGGATGGCGGCAACTCATCTTAC
Forward primer for 36.2050 (SEC 14) ORF in L. 
infantum
OL1985 GCAGGATCCTCACTTCGGCAAACCGTTCTTTC
Reverse primer for 36.2050 (SEC 14) ORF in L  
infantum
OL1986 GCACCCGGGATGTCCGCCATCATCATCAC
Forward primer for 20.100 (Xylanase) ORF in L, 
infantum
OL1987 GCAGGATCCTCAGTGACGAGGAAGAAAGC
Reverse primer for 20.100 (Xylanase) ORF in L. 
infantum
OL1997 GCAAAGCTTCTCTAACTCTTTCTCTATCGCTG
Forward PCR primer for amplifying SEC 14 5’ 
flanking region of L. infantum
OL1998 GCAGTCGACGGTGAGTGACACGTCCTTTGCG
Reverse PCR primer for amplifying SEC14 5’ 
flanking region o f F. infantum
OL1999 GCACCCGGGGCTACGGATGCCCGTGTGCTGG
Forward PCR primer for amplifying SEC14 3’ 
flanking region of L  infantum
OL2000 GCAAGATCTAAAAGGGAAAAGGAGTCCATCAC
Reverse PCR primer for amplifying SEC 14 3 ’ 
flanking region of L. infantum
OL2051 GCACCCGGGATGGCCGATGTGCAGCTCTCC Forward primer for 28,0330 ORF in L. infantum
OL2052 GCAGGATCCGTCACATATCCATCAAGATTTCG
Reverse primer for 28.0330 ORF in 
L . infantum
OL2053 GCACCCGGGATGGGGCGAATCGACTCCTC Forward primer for 36.2750 ORF in L. infantum
OL2054 GCAGGATCCTCAAGAGTTAGTCGGCAGCCGAG Reverse primer for 36.2750 ORF in L. infantum
OL2095 GGCTCCAGCGGGCAAACTAC
Forward sequencing primer for xylanase 
L. infantum
OL2096 GACGTTCACCTTACCCTGCTG
Reverse sequencing primer for xylanase 
L. infantum
OL2097 GACAACCACTACCGCACCGAG
Forward sequencing primer for xylanase 
L. infantum
OL2098 GGCGTTATGAGGATGCGGGAAG
Forward sequencing primer for 28.0330 
L. infantum
OL2099 CTTCCCGCATCCTCATAACGCC
Reverse sequencing primer for 28.0330 
L. infantum
OL2100 CATCTGCCTCGCCTTTAACG
Forward sequencing primer for 28.0330 
L. infantum
OL2101 CGTTAAAGGCGAGGCAGATG
Reverse sequencing primer for 28.0330 
L. infantum
OL2102 CATGAGGAAGCGGCACGGGAG
Forward sequencing primer for 36.2750 
L. infantum
OL2103 CTCCCGTGCCGGTTCCTCATG
Reverse sequencing primer for 36.2750 
L. infantum
OL2104 CACGCATCGCCCGCATCG
Forward sequencing primer for 36.2750 
L. infantum
OL2105 CGATGCGGGCGATGCGTG
Reverse sequencing primer for 36.2750 
L. infantum
OL2106 GGAGCACGATGAGCAGCACG
Forward sequencing primer for 36.2750 
L. infantum
OL2107 CGTGCTGCTCATCGTGCTCC
Reverse sequencing primer for 36.2750 
L . infantum
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OL2112 ATGGGTCCAATCGACTCCTC
Forward primer for 36.2750 equivalent 
pseudogene in L. major
OL2113 GAACAGATCCACAGCGCCAC
Reverse primer for 36.2750 equivalent 
pseudogene in L. major
OL2114 GTCCGGTGTACATTGACCAAG
Forward primer for 28.0330 equivalent 
pseudogene in L  major
OL2115 TCACATATCCATCAAGATTTCG
Reverse primer for 28.0330 equivalent 
pseudogene in L  major
OL2116 ATGTCCACCATCATCATCAC
Forward primer for xylanase equivalent 
pseudogene in L. major
OL2117 CGGCTGCCTCAGTGAGGAG
Reverse primer for xylanase equivalent 
pseudogene in L. major
OL2285 CAAAGCGCTCCCGTAGCAT
Reverse primer for PCR and sequencing SEC 14 
in 1. infantum
OL2300 GGACGCCAACTTTTACCATCTTTC
Forward PCR primer for 5’ integration check at 
SEC14 locus ofZ-. infantum
OL2301 AGAAGCAAGGGCACTGGGCG
Reverse PCR primer for 3 ’ integration check at 
SEC 14 locus of A infantum
OL2403 GACGGTGGAGCAGGACAAC
Forward sequencing primer for SEC 14 ORF of 
L. infantum
OL2404 GTTGTCCTGCTCCACCGTC
Reverse sequencing primer for SEC 14 ORF of 
L. infantum
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CHAPTER 3 - RESULTS
3.1. Cloning and Sequencing of Four Z. //i/ii«^Mm-Specific Genes
With the recent publication of the genomes of L. infantum and L. braziliensis, 
together with the comparative analysis of the gene content compared with L. major, 
a small subset of genes have been identified as being specific to L. infantum 
(Peacock et ak, 2007). More than two thirds of all genes in Leishmania encode 
hypothetical proteins and roughly the same proportion of hypothetical genes is 
represented in the subset of L. infantum specific genes. It is therefore important not 
to neglect the hypothetical genes when further characterisation is made.
To this end, the four L. infantum genes selected for this study were:
• LinJ28.0330 (hypothetical)
• LinJ36.2750 (hypothetical, with some domain homology (TRF4))
• LinJ20.1200 (putative endo-1,4-P-xylanase precursor)
• LinJ36.2050 (putative SEC 14 cytosolic factor)
The analysis of these genes consists of three parts:
1. Sequence analysis of GeneDB sequence for each gene and encoded protein;
2. Amplification, cloning and sequencing of each gene from L. infantum to
confmn GeneDB data as well as to ensure PCR products can be used for 
further experiments and
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3. Amplification, cloning and sequencing of each gene from L. donovani to 
determine if genes are intact in another species that can cause visceral 
leishmaniasis.
3.1.1 Bioinformatic Analysis of the Encoded Proteins of Each Gene
3.1.1.1 LinJ28.0330 Protein
Protein BLAST searches (http://www.ncbi.nlm.nih.gov/BLAST/) with the amino 
acid sequence of LinJ28.0330 protein against the non-redundant protein sequences 
database revealed no significant homology to any other protein known. Moreover, 
checks against the Conserved Domain Database (NCBI) revealed no significant 
homology to any known protein domain, so nothing can be surmised about the 
potential role of this protein in L. infantum without further study.
3.1.1.2 LinJ36.2750 Protein
The amino acid sequence of LinJ36.2750 was also checked against the non- 
redundant protein sequences database and the Conseived Domain Database. The 
encoded protein, although hypothetical, contains a domain that has homology to 
Topoisomerase-Related Function 4 (TRF4), a domain related to the TRF4 proteins of 
the yeast Saccharomyces cerevisiae (Figure 3.1.1 A). Reciprocal BLAST analysis 
with the S. cerevisiae TRF4 amino acid sequence against predicted proteins in L. 
infantum, L. major and L. braziliensis (GeneDB Omniblast) revealed several genes 
encoding TRF4 domains, of which LinJ36.2750 was the third highest hit (Figure
3.LIB). This provides a good basis on which to plan future experiments, beyond the 
scope of this thesis.
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g b I A A D 4  5 1 9 8 . 1 1 A F 0 8 9 8 9 6  1 t o p o i s o m e r a s e - r e l a t e d  f u n c t i o n  p r o t e i n  
r e f  IXP 0 0 1 3 7 1 5 3 7 . 1 1 PR E D IC T ED : s i m i l a r  t o  POLS p r o t e i n  [ M o n o d e l p  
PA P a s s o c i a t e d  d o m a i n  c o n t a i n i n g  5 ,  i s o f o r m  C R . . .  
PAP a s s o c i a t e d  d o m a i n  c o n t a i n i n g  5 ,  i s o f o r m  C R . . .  
r e f  IXP 0 0 1 2 5 6 5 1 6 . 1 1 PR EDIC TED : s i m i l a r  t o  P A P - a s s o c i a t e d  d o m a . . .  
r e f  IXP 0 0 1 5 0 1 2 3 8 . 1 1 PRE D IC T ED : s i m i l a r  t o  L A K - 1  [ E q u u s  c a b a l l u s ]  
s p I Q 6 8 E D 3 I P A D 5  MOUSE P A P - a s s o c i a t e d  d o m a i n - c o n t a i n i n g  p r o t e i n . . .  
r e f  IXP 1 3 4 4 2 2 . 8 |  PREDICTED : s i m i l a r  t o  P A P - a s s o c i a t e d  d o m a i n - . . .  
P a p d 5  p r o t e i n  [M us m u s c u i u s ]
PA P a s s o c i a t e d  d o m a i n  c o n t a i n i n g  5 ,  i s o f o r m  C R . . .  
r e f  IXP 0 0 1 0 6 2 7 0 3 . l |  PR EDIC TED : s i m i l a r  t o  DNA p o l y m e r a s e  s i g m a
g b j A A H 7 6 8 7 2 . 1 |
em b  I_____________
q b | A A I 3 3 1 0 2 . 1 |  
r e f l X P  6 9 7 1 1 5 . 1 1
g b | E A W 8 2 7 4 9 . l |
g b | E A W 8 2 7 5 0 . l |
g b | A A H 8 0 3 1 4 . 1 1 
g b | E A W 8 2 7 4 7 . l |
7 2  . 0
7 1 . 6
7 1 . 2  
7 0  . 9 
7 0  . 5 
6 9 .  7
6 9 . 7  
6 9  . 7
6 9 . 3
6 9 . 3  
6 9  . 3
6 9 . 3
6 9 . 3  
6 8  . 9
. 68  . 2  
. 6 8 . 2  
68  . 2  
• 68  . 2  
[ 6 7 . 8
l e - 1 0
2 e - 1 0
2 e - 1 0
3 e - 1 0
5 e - 1 0
6 e - 1 0
7 e - 1 0
7 e - 1 0
9 e - 1 0
9 e - 1 0
l e - 0 9
l e - 0 9
l e - 0 9
l e - 0 9
2 e - 0 9
2 e - 0 9
2 e - 0 9
2 e - 0 9
3 e - 0 9
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Sum
S e q u e n c e s  p r o d u c i n g  H i g h - s c o r i n g  S e g m e n t  P a i r s  :
H i g h
S c o r e
P r o b a b i l i t y  
P ( N )  N
L i n J 0 7 V 3 . 0 7 8 0 1 1 1 t o p o i s o m e r a s e - r e l a t e d  f u n c t i o n  p r o t e i n - . . . 2 9 2 2 . 6 e - 2 4 2
L i n J 2  6 V 3 . 0 4 8 0 1 1 1 DNA p o l y m e r a s e  s i g m a - l i k e  p r o t e i n | L e i s h . . 1 3 6 6 . 6 e - 1 2 3
L i n J 3 6 V 3 . 4 1 9 0 I 1 1 h y p o t h e t i c a l  p r o t e i n | L e i s h m a n i a  i n f a n t u . . 9 8 1 . 3 e - 0 7 2
L i n J 0 4 V 3 . 0 4 9 0 11 1 h y p o t h e t i c a l  p r o t e i n ,  c o n s e r v e d | L e i s h m a . . . 1 0 2 6 . 5 e - 0 6 2
L i n J 3 2 V 3 . 2 6 0 0 1 1 [ h y p o t h e t i c a l  p r o t e i n ,  c o n s e r v e d | L e i s h m a . . 1 1 2 4 . 8 e - 0 5 1
L i n J 1 4 V 3 . 1 2 6 0 1 1 1 p o l y ( A )  p o l y m e r a s e ,  p u t a t i v e | L e i s h m a n i a . . 1 0 2 0 . 0 0 1 6 1
L i n J 2  9 V 3 . 2 7 1 0 1 1 1 p o l y ( A )  p o l y m e r a s e ,  p u t a t i v e | L e i s h m a n i a . , 9 9 0 . 0 0 2 1 1
L i n J 2 1 V 3 . 2 1 1 0 1 1 1 h y p o t h e t i c a l  p r o t e i n ,  c o n s e r v e d | L e i s h m a . . 9 9 0 . 0 0 2 7 2
L i n J 2 0 V 3 . 0 6 7 0 1 1 1 h y p o t h e t i c a l  p r o t e i n ,  c o n s e r v e d | L e i s h m a . . 84 0 . 0 6 8 1
L i n J 2  8 V 3 . 0 8 4 0 111 h y p o t h e t i c a l  p r o t e i n ,  c o n s e r v e d | L e i s h m a . . 6 8 0 . 7 2 2
L i n J 2  6 V 3 . 0 3 8 0 1R E T 2 11 RNA e d i t i n g  3 '  t e r m i n a l  u r i d y l y l  t r . . 5 9 0 . 8 4 2
L i n J 1 4 V 3 . 1 0 2 0 1 3 ' T U T A S E 11RNA e d i t i n g  3 '  t e r m i n a l  u r i d y l y . . 7 7 0 . 9 8 2
L i n J 2 4 V 3 . 0 2 5 0 1 1 1 h y p o t h e t i c a l  p r o t e i n ,  c o n s e r v e d | L e i s h m a . . 7 4 0 . 9 9 9 8 1
L i n J 3 1 V3 . 0 2 3 0 11 1 h y p o t h e t i c a l  p r o t e i n ,  c o n s e r v e d | L e i s h m a . . 6 1 0 . 9 9 9 9 1
Figure 3.1.2: Analysis of LinJ36.2750 sequence. A) Protein BLAST analysis of 
LinJ36.2750 was carried out (http://www.ncbi.nlm.nih.gov/BLAST/) showing the 
known proteins with significant homology. B) Reciprocal BLAST with S. cerevisiae 
TRF4. Note that Linj36.2750 has been renamed Linj36 V3.4190 (shown in bold 
typeface) in the latest release of the L. infantum genome.
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3.1.1.3 LinJ20.1200 (Endo-l,4-P-xylanase precursor)
BLASTp analysis of the amino acid sequence of this L. infantum-specific protein 
reveals that the most similar proteins are bacterial (Figure 3.1.2A). The proteins 
with highest homology are found in Solibacter usitatus and Acidobacteria 
bacterium, raising the possibility that the genes were acquired by horizontal gene 
transfer as has been seen previously with the L. wq/'oT’-specific gene encoding PFPl 
(Eschenlauer et al., 2006). Reciprocal BLAST of the Solibacter usitatus amino acid 
sequence against predicted protein databases in GeneDB for L. infantum, L. major 
and L. braziliensis has identified LinJ20.1200 as the top hit in L, infantum (with a 
P/N value of 5.4e-37) but has no significant homology to proteins in either of the 
other two species (Figure 3.1.2B).
A
S e q u e n c e s  p r o d u c i n g  s i g n i f i c a n t  a l i g n m e n t s ;
r e f  
r e f  
r e f
g b | E D 0 1 0 8 0 2 . I j  
r e f  
r e f  
em b  
r e f  
r e f  
r e f  
r e f  
r e f  
r e f  
r e f  
r e f  
r e f  
r e f  
r e f  
r e f  
r e f  
em b
Y P _ 8 2 3 3 4 8 . 1 1  p u t a t i v e  e s t e r a s e  [ S o l i b a c t e r  u s i t a t u s  E l l i n . .
YP 5 9 2 3 2 0 . 1 1 p u t a t i v e  e s t e r a s e  [ A c i d o b a c t e r i a  b a c t e r i u m  B . .
ZP 0 1 7 1 8 0 6 5 . 1 ]  p r e d i c t e d  x y l a n a s e  [ A l g o r i p h a g u s  s p .  P R l ]
h y p o t h e t i c a l  p r o t e i n  B A C O V A _ 0 3 4 3 5  [ B a c t e r o i d e s . .  
p u t a t i v e  e s t e r a s e  [ S o l i b a c t e r  u s i t a t u s  E l l i n . .
p u t a t i v e  e s t e r a s e  [ S o l i b a c t e r  u s i t a t u s  E l l i n . .
p u t a t i v e  a c e t y l  x y l a n  e s t e r a s e  [ u n i d e n t i f i e d  m i c  
p u t a t i v e  e s t e r a s e  [ S o l i b a c t e r  u s i t a t u s  E l l i n . .
1 1 h y p o t h e t i c a l  p r o t e i n  E U B V E N _ 0 1 1 2 6  [ E u b a c t e . .  
p u t a t i v e  e s t e r a s e  [ S o l i b a c t e r  u s i t a t u s  E l l i n . .
p u t a t i v e  e s t e r a s e  [ A c i d o b a c t e r i a  b a c t e r i u m  E . .
g l y c o s i d e  h y d r o l a s e  f a m i l y  4 3  [ B a c t e r o i d e . . 
P o s s i b l e  x y l a n  d e g r a d a t i o n  e n z y m e  { a l p h a / b . .
p u t a t i v e  e s t e r a s e  [ F l a v o b a c t e r i u m  j o h n s o n . . 
p u t a t i v e  g l y c o s y l  h y d r o l a s e  e x o e n z y m e  [ A l g . . 
p r e d i c t e d  x y l a n a s e  [ A l g o r i p h a g u s  s p .  P R l ]  . .  
p u t a t i v e  g l y c o s y l  h y d r o l a s e  e x o e n z y m e  [ R o b . ,  
p u t a t i v e  x y l a n a s e  [ P a r a b a c t e r o i d e s  d i s t a s . .  
Y P _ 8 2 4 3 3 2 . l |  p u t a t i v e  e s t e r a s e  [ S o l i b a c t e r  u s i t a t u s  E l l i n . .  
Z P _ 0 1 8 8 2 2 1 5 . 1 1  p u t a t i v e  e s t e r a s e  [ P e d o b a c t e r  s p .  B A L 3 9 ]  > . .  
C A J 1 9 1 2 2 . 1 ]  a c e t y l  x y l a n  e s t e r a s e  [ u n i d e n t i f i e d  m i c r o o r g a n i s
Y P _ 8 2 5 7 1 0 . 1  
Y P _ 8 2 4 3 3 3 . 1  
C A J 1 9 1 Q 9 , 1 |  
Y P _ 8 2 4 2 6 0 . 1  
Z P 0 2 0 2 5 8 7 1  
Y P _ 8 2 4 2 5 7 . 1  
Y P _ 5 9 0 9 3 4 . 1  
Y P _ 0 0 1 2 9 7 3 8 4 . 1  
Z P _ 0 1 7 2 0 9 9 9 . 1 [  
Y P _ 0 0 1 1 9 6 2 0 8 . 1  
Z P _ 0 1 7 1 8 1 6 8 . 1 |  
Z P 0 1 7 1 8 1 7 0 . 1 1 
Z P _ 0 1 1 2 0 S 2 2 . l |  
YP 0 0 1 3 0 3 3 6 4 . 1
S c o r e E
( B i t s ) V a l u e
1 4 9 5 e - 3 4
1 4 5 5 e - 3 3
1 3 4 l e - 2 9
1 2 9 4 e - 2 8
1 2 7 l e - 2 7
1 2 7 l e - 2 7
1 2 5 6 e - 2 7
1 2 4 l e - 2 6
1 2 0 l e - 2 5
1 1 9 3 e - 2 5
1 1 9 6 e - 2 5
1 1 4 2 e - 2 3
1 1 2 4 e - 2 3
1 1 2 5 e - 2 3
1 1 1 7 e - 2 3
1 1 0 3 e - 2 2
1 0 8 6 e - 2 2
1 0 3 2 e - 2 0
1 0 3 2 e - 2 0
1 0 3 2 e - 2 0
1 0 0 l e - 1 9
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Summary for: L. brasiliensis predicted proteins [wublastp], for query: UNKNOWN-QUERY
Name: LbrM23.0510 Score: 77 (P/N): 0.16 N 1
Name: LbrM22.0760 Score: 83 (P/N): 0.22 N I
Name: LbrM35.5610 Score: 78 (P/N): 0.29 N 1
Name: sequence orphan Score: 67 (P/N): 0.94 N 1
Name: LbrM26.I220 Score: 71 (P/N): 0.96 N 1
Summary for: L. infantum predicted proteins [wublastp], for query: UNKNOWN-QUERY
Name: LinJ20.1200 Score; 382 (P/N): 5.4C-37 N 1
Name: LinJ28.0850 Score: 68 (P/N): 0.38 N 1
Name: LinJ32.2890 Score: 77 (P/N): 0.43 N 1
Name: LinJ23.0520 Score: 72 (P/N): 0.58 N 1
Name: LinJ08.0490 Score: 69 (P/N): 0.76 N 1
Summary for: L. major predicted proteins [wublastp], for query: UNKNOWN-QUERY
Name: LmJF 16.0630 Score: 80 (P/N); 0.24 N: 1
Name: LmjF06.0470 Score: 82 (P/N) : 0.27 N: 1
Name: LmjF23.0490 Score: 74 (P/N) : 0.32 N: 1
Name: LmjF28.0825 Score: 68 (P/N): 0.38 N: 1
Name; LmJF35.5000 Score: 71 (P/N] : 0.57 N: 1
Figure 3.1.2: Analysis of LinJ20.1200 sequence. A Protein BLAST analysis of 
LinJ20.1200 (xylanase) was earned out (http://www.ncbi.nlm.nih.gov/BLAST/) 
showing the known proteins with significant homology. B Reciprocal BLAST 
(Omniblast) analysis of the Solibacter usitatus amino acid sequence against the L. 
braziliensis, L. infantum and L. major predicted protein databases in GeneDB.
3.1.1.4 LinJ36.2050 (SEC 14 Cytosolic Factor)
This gene has been identified as encoding a putative orthologue of the yeast Secl4p 
protein, which is involved in membrane restructuring and secretory vesicle formation 
at the trans-Golgi network (TGN). Interestingly, when the yeast amino acid 
sequence is reciprocally blasted against the predicted proteins database for L.
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infantum, L. major and L. braziliensis, the protein encoded by LinJ36.2050 is 
actually the second most significant hit (Figure 3.1.3).
Summary for: L. infantum predicted proteins [wublastp], for query: UNKNOWN-QUERY
Name: LinJ35,3630 Score: 116 (P/N): 1.7e-13 N:
Name: LinJ36.2050 Score: 176 (P/N): 1.3e-12 N:
Name: LinJ15.0640 Score: 117 (P/N): 9.2e-10 N:
Name: LW30.2020 Score: 99 (P/N): 1.4e-08 N:
Name: LinJ36.3340 Score: 121 (P/N): 6.4e-06 N:
ummary for: L. major predicted proteins [wublastp], for query: UNKNOWN -QUERY
Name: LmjF3 5.3560 Score: 117 (P/N) 6.4e-14 N
Name: LmjF15.0610 Score: 120 (P/N) 2.2e-10 N
Name: LmjF36.3430 Score: 134 (P/N) 2.3e-07 N
Name: LmjF30.1680 Score: 90 (P/N) 2.7e-07 N
Name: LmjF31.2050 Score: 72 (P/N) 0.0060 N
Summary for: L. brasiliensis predicted proteins [wublastp], for query: UNKNOWN-QUERY
Name: LbrM32_Y2.1420 Score: 160 (P/N) 4.5e-12 N 2
Name: LbrM34_V2.3490 Score: 111 (P/N) l.le-11 N 2
Name: LbrM15_V2.0650 Score: 132 (P/N) 1.le-10 N 2
Name: LbrM35_V2.3660 Score: 142 (P/N) 2.8e-08 N 1
Name: LbrM31_V2.2310 Score: 91 (P/N) 3.9e-06 N 3
Figure 3.1.3: OmniBLAST output from analysis of the amino acid sequence of 
yeast Secl4p against the predicted protein databases for all three Leishmania species 
in GeneDB.
The top hit in L. infantum and L. major is LinJ35.3630 and LmjF35.3560 (which are 
orthologues of each other). Closer analysis of the proteins has revealed that the 
domain structure of these two proteins is, perhaps unsurprisingly, more similar to 
yeast Secl4p than the L. infantum-spQcific gene (LinJ36.2050) under investigation 
(Figure 3.1.4). The domains identified in this analysis are the CRAL__TRIO domain
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and the SEC 14 domain. These domains are lipid binding domains and they are 
thought to be part of the same domain (Saito et al., 2007) even though they are 
annotated as separate domains in the NCBI Conserved Domain Database. This is 
because not all SEC 14 domain containing proteins possess the CRAL TRIO portion 
(Saito et al., 2007). This seems to be true of the L. m^âw/ww-specific LinJ36.2050, 
which has a “CAP_GLY” domain instead. These domains have been shown in other 
systems to be involved in associating CAP GLY-containing proteins with elements 
of the cytoskeleton, notably microtubules (Mishima et al., 2007). Interestingly, the 
only known proteins with this domain structure are found in L. infantum and its 
orthologue in T. cruzi. The gene is also missing from T. brucei.
L. infantum
“SEC14”
LinJ36.2050
S. cerevisiae 
SEC14p
L. infantum
Hypothetical
LinJ35.3630
L. major
Hypothetical
LmjF35.3560
L. braz 
Hypothetical 
LbrM32 V2.1420
.
, .
Figure 3.1.4: Domain structure of putative Secl4p orthologues in Leishmania.
Protein BLAST analysis was carried out using the NCBI Blast server. 
(http://www.ncbi.nlm.nih.gov/BLAST/).
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3.1.2 Cloning and Sequencing of the Four Genes from L. infantum
In order to confirm that the sequence held on GeneDB for each of the foin genes 
mentioned above, the open reading frames must be isolated and characterised by 
sequencing. To this end, primers were designed to each of the four genes in order to 
amplify the complete open reading frames (ORFs) (Table 3.1.1). Xmal and BamHl 
restriction sites were engineered onto the 5’ and 3’ ends respectively, of the primers 
and therefore the PGR products, to allow eventual cloning and expression fi'om the 
Leishmania episomal vector pXG.
Table 3.1.1: Designed primers for PCR for four genes from L. infantum (restriction 
sites are underlined)
GeneDB
Designation
LinJ28.0330
LinJ36.2750
LinJ20.1200
(Xylanase)
LinJ36.2050
(SEC14)
Designed
Primers
OL2051
OL2052
OL2053
OL2054
OL1986
OL1987
OL1984
OL1985
Primer Sequence
GCACCCGGGATGGCCGATGTGCAGCTCTCC
GCAGGATCCGTCACATATCCATCAAGATTTCG
GCACCCGGGATGGGGCGAATCGACTCCTC
GCAGGATCCTCAAGAGTTAGTCGGCAGCCGAG
GCACCCGGGATGTCCGCCATCATCATCAC
GCAGGATCCTCAGTGACGAGGAAGAAAGC
GCACCCGGGATGGCGGCAACTCATCTTAC
GCAGGATCCTCACTTCGGCAAACCGTTCTTTC
3.1.2.1 PCR of Four T. Specific Genes
Polymerase chain reaction (PCR) was carried out to amplify the fragments. The 
primers were initially tested at a range of annealing temperatures to deteimine the
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optimal conditions. This was done with a variety of proof-reading enzymes in either 
the supplied PCR buffer or in the lOx PCR buffer commonly used in the Mottram 
laboratory. The fragments were amplified and cloned by using T-Vector such as 
pGEM-T Easy (Promega) or pCR2.1 TOPO TA (Invitrogen). This required the 
addition of A-overhangs by the inclusion of Taq DNA polymerase at the end of the 
PCR with a 10 minutes incubation step at 72°C, as the proof-reading enzymes do not 
leave overhanging A-residues. Reactions were electrophoresed on gels to visualise 
and allow purification of the appropriate DNA fragment by gel extraction (Figure 
3.1.5).
3.0kb2.0kb1.5kb —]
1 .Okb H
1 .5kb H
1 .Okb H
1.5kb
I.Okb
Figure 3.1.5: PCR Amplification for each of the four genes under investigation. A) 
LinJ28.0330 ORE PCR product (predicted size is ~1.4kb). B) LinJ36.2750 ORE PCR 
product (predicted size is ~2.2kb). C) LinJ20.1200 (Xylanase) ORE PCR product 
(predicted size is ~1.3kb). D) LinJ36.2050 (SEC 14) ORE PCR product (predicted 
size is ~1.3kb).
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Once PCR products were cloned into a T-vector, they were sent to the University of 
Dundee Sequencing Service to be sequenced using a variety of primers both internal 
to the gene and external, within the plasmid backbone.
3.1.3 Sequence Analysis
Sequence fragments for each gene were assembled into contigs and analysed using 
the ContigExpress Software (Vector-NTI Advance vlO, Invitrogen). Contiguous 
sequence of each open reading frame was aligned with the published sequence on 
GeneDB using Align-X software (Vector-NTI, Invitrogen) and these are shown in 
Figure 3.1.6. Note that only a single PCR fragment was cloned and sequenced for 
each ORF, so errors may have been introduced by PCR. Independent clones would 
need to be sequenced to confirm this.
A LinJ28.0330 (Hypothetical) Alignment
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
(1
(1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 5 1
( 5 1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 1 0 1
( 1 0 1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 1 5 1
( 1 5 1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 2 0 1
( 2 0 1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 2 5 1
( 2 5 1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 3 0 1
( 3 0 1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 3 5 1
( 3 5 1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 4 0 1
( 4 0 1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 4 5 1
( 4 5 1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 5 0 1
( 5 0 1
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 5 5 1
( 5 5 1
1 5 0
ATGGCCGATGTGCAGCTCTCCAACTCCAGCAATGTCAAGGCTGTCTATGC 
ATGGCCGATGTGCAGCTCTCCAACTCCAGCAATGTCAAGGCTGTCTATGC
5 1 1 0 0
AGGACACAGCTTGAGCCTCTTCATGGACCTCCGCCCGCCGGCGGAGGTGC
AGGACACAGCTTGAGCCTCTTCATGGACCTCCGCCCGCCGGCGGAGGTGC
101 1 5 0
TGGCGACGTGCAGCGGCTCCGTTGTCGAGGACCTGCCCGTGACACTAAGT
TGGCGACGTGCAGCGGCTCCGTTGTCGAGGACCTGCCCGTGACACTAAGT
1 5 1 2 0 0
GTCATGCTGCGTCGCATCCATAGCGAAAGCGAGACCCCGCTTTCGTTTCG
GTCATGCTGCGTCGCATCCATAGCGAAAGCGAGACCCCGCTTTCGTTTCG
2 0 1 2 5 0
TTGTTCTTCCTCGCATCGACTTCTCACCTACGTGCAGTGCGAAGACGGTG
TTGTTCTTCCTCGCATCGACTTCTCACCTACGTGCAGTGCGAAGACGGTG
2 5 1 3 0 0
CTGGCGGCGATGCTGTCCAGCTGGGAATGAGCGGTAACAACCTGCTCAAG
CTGGCGGCGATGCTGTCCAGCTGGGAATGAGCGGTAACAACCTGCTCAAG
3 0 1 3 5 0
GTCACTATAGACCTTGCTACCTTCCCGGACCGGTTGCAGCGACTAGCAGC
GTCACTATAGACCTTGCTACCTTCCCGGACCGGTTGCAGCGACTAGCAGC
3 5 1 4 0 0
GGCCGATGTCGCTGCAGCTGAGCATGCCTTGCTTGATCAGTCGTGGGTGA
GGCCGATGTCGCTGCAGCTGAGCATGCCTTGCTTGATCAGTCGTGGGTGA
4 0 1 4 5 0
TCGGCTCGCGGTTCCGCCTCTCAATGCAGCTGCGTACCAGAGCGCGTGCC
TCGGCTCGCGGTTCCGCCTCTCAATGCAGCTGCGTACCAGAGCGCGTGCC
4 5 1 5 0 0
GAGTGGCCACCCCTCGTCGCCCCGCAGTGGAGCGAGTCCAGTGACGGCTG
GAGTGGCCACCCCTCGTCGCCCCGCAGTGGAGCGAGTCCAGTGACGGCTG
5 0 1 5 5 0
CCTTGTCCCGACACCTTGCAGCCATCACATGGACAATCATGACAGCGCGG
CCTTGTCCCGACACCTTGCAGCCATCACATGGACAATCATGACAGCGCGG
5 5 1 6 0 0
GCGTTATGAGGATGCGGGAAGAGTTCGCCGCGAAGGGCGTATCCGCGTCG
GCGTTATGAGGATGCGGGAAGAGTTCGCCGCGAAGGGCGTATCCGCGTCG
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c l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 6 0 1 )
( 6 0 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 6 5 1 )
( 6 5 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 7 0 1 )
( 7 0 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 7 5 1 )
( 7 5 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 8 0 1 )
( 8 0 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 8 5 1 )
( 8 5 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 9 0 1 )
( 9 0 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 9 5 1 )
( 9 5 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 1 0 0 1 )
( 1 0 0 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 1 0 5 1 )
( 1 0 5 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 1 1 0 1 )
( 1 1 0 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 1 1 5 1 )
( 1 1 5 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 1 2 0 1 )
( 1 2 0 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 1 2 5 1 )
( 1 2 5 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 1 3 0 1 )
( 1 3 0 1 )
C l o n e d 2 8 . 0 3 3 0  S e q  
L i n J 2 8 . 0 3 3 0
( 1 3 5 1 )
( 1 3 5 1 )
B LinJ36.2750 (Ï
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 )
( 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 5 1 )
( 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 0 1 )
( 1 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 5 1 )
( 1 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 2 0 1 )
( 2 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 2 5 1 )
( 2 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 3 0 1 )
( 3 0 1 )
6 0 1  6 5 0
CCCAGTATCGTTCGGCGGAATCGGCCACTGTCTCTATACGACAAGTCAGC
CCCAGTATCGTTCGGCGGAATCGGCCACTGTCTCTATACGACAAGTCAGC
6 5 1  7 0 0
ACCGCGCTCTCAGTTGAAGGGTCCGGTGTACATTGACCAAGAGCTGTTCC
ACCGCGCTCTCAGTTGAAGGGTCCGGTGTACATTGACCAAGAGCTGTTCC
7 0 1  7 5 0
CGATCGTTCGTATTTTGTTTGTTCCTCAACTCTACACGGAGGCCATCCCG
CGATCGTTCGTATTTTGTTTGTTCCTCAACTCTACACGGAGGCCATCCCG
7 5 1  8 0 0
ACGGCAACGGCGGTGTTGCGGAGCATGACGGTGCAAGTCGGAGTGGAGCG
ACGGCAACGGCGGTGTTGCGGAGCATGACGGTGCAAGTCGGAGTGGAGCG
8 0 1  8 5 0
TTGCCGCGAGAGCCGCGGCGGCAAGCCGCTTCGTCGCGCCCTGCGAGACC
TTGCCGCGAGAGCCGCGGCGGCAAGCCGCTTCGTCGCGCCCTGCGAGACC
8 5 1  9 0 0
GCAGCACTAAAGACAACGTCGCCGTGCTCGATCGCGTGCCGGCAAGTAGC
GCAGCACTAAAGACAACGTCGCCGTGCTCGATCGCGTGCCGGCAAGTAGC
9 0 1  9 5 0
AGCACGTTAGATGAGGAGAGCAAAGCCCTACTGCAACCGTACGAGGCCAT
AGCACGTTAGATGAGGAGAGCAAAGCCCTACTGCAACCGTACGAGGCCAT
9 5 1  1 0 0 0
CTGCCTCGCCTTTAACGCCCATGTTCGTCAGCCCTCAATGACGTCGGTCA
CTGCCTCGCCTTTAACGCCCATGTTCGTCAGCCCTCAATGACGTCGGTCA
1 0 0 1  1 0 5 0
CTGCCTACGACGTGGCACACGCGAGGCGACTTGTTGTGCAGGACTACACC
CTGCCTACGACGTGGCACACGCGAGGCGACTTGTTGTGCAGGACTACACC
1 0 5 1  1 1 0 0
TTTGAGGTGATGGTCACGGCAGCGAGGATGAAAAGCGAAACCGTGGAGAC
TTTGAGGTGATGGTCACGGCAGCGAGGATGAAAAGCGAAACCGTGGAGAC
1 1 0 1  1 1 5 0
CGTGCAGCGCGCTATTCAGGCCTATCAGTACGAGAGCGGCGATGCAGATG
CGTGCAGCGCGCTATTCAGGCCTATCAGTACGAGAGCGGCGATGCAGATG
1 1 5 1  1 2 0 0
TGCTGGGCATGAACCTCGATGAAGCCGTCAGCTCCGTCGAAGAGCGGTTT
TGCTGGGCATGAACCTCGATGAAGCCGTCAGCTCCGTCGAAGAGCGGTTT
1 2 0 1  1 2 5 0
GGCTACATGAAGGACGCGCCGTCGGTGGACTTGATGAGCTTTCACCATGT
GGCTACATGAAGGACGCGCCGTCGGTGGACTTGATGAGCTTTCACCATGT
1 2 5 1  1 3 0 0
TGTTTGGGAGGCGATGCGAGCATGCATGGTGGCCGACGTCACTTCCAGTG
TGTTTGGGAGGCGATGCGAGCATGCATGGTGGCCGACGTCACTTCCAGTG
1 3 0 1  1 3 5 0
CACTTGCAAACGAACTGGAGGACGAGCTCGACCGCTATGAGGACCGCATC
CACTTGCAAACGAACTGGAGGACGAGCTCGACCGCTATGAGGACCGCATC
1 3 5 1  1 3 7 4
AACGAAATCTTGATGGATATGTGA
AACGAAATCTTGATGGATATGTGA
1 5 0
ATGGGGCGAATCGACTCCTCTTGTGTCGCTGCCACGGTGACGCCTAGCAA 
ATGGGGCGAATCGACTCCTCTTGTGTCGCTGCCACGGTGACGCCTAGCAA
5 1 1 00
GGTCGGCGCATCGTCGTCTTGTCCCGGCACGGCGACAAGCACTGGCAAGA
GGTCGGCGCATCGTCGTCTTGTCCCGGCACGGCGACAAGCACTGGCAAGA101 1 5 0
TAGACGAGCCTGCTTCTCGCGCCGCTGCCCCGCAGGGCCGGGCGCAGCGA
TAGACGAGCCTGCTTCTCGCGCCGCTGCCCCGCAGGGCCGGGCGCAGCGA
1 5 1 200
TGTGGCCGAGCGCGACCCGCCCAGATGCACAACAGCCTCAGTGCGGGGAT
TGTGGCCGAGCGCGACCCGCCCAGATGCACAACAGCCTCAGTGCGGGGAT
2 0 1 2 5 0
GTGTGATAACCAACAGCAGCACGCCGCAGGCGTTTGGAAGTTGATTGCAG
GTGTGATAACCAACAGCAGCACGCCGCAGGCGTTTGGAAGTTGATTGCAG
2 5 1 3 0 0
GGCCGCAGAGCGCCTCCACGACTCCGCCGCCGCTCGTGATGGGTGACGGC
GGCCGCAGAGCGCCTCCACGACTCCGCCGCCGCTCGTGATGGGTGACGGC
3 0 1 3 5 0
ACAGGCGGCGAGGATCATGCGCAGGCTGCCCACACCGGCGTCCGGTGGAC
ACAGGCGGCGAGGATCATGCGCAGGCTGCCCACACCGGCGTCCGGTGGAC
52
3 5 1 4 0 0
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 3 5 1 )
( 3 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 4 0 1 )
( 4 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 4 5 1 )
( 4 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 5 0 1 )
( 5 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 5 5 1 )
( 5 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 6 0 1 )
( 6 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 6 5 1 )
( 6 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 7 0 1 )
( 7 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 7 5 1 )
( 7 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 8 0 1 )
( 8 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 8 5 1 )
( 8 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 9 0 1 )
( 9 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 9 5 1 )
( 9 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 0 0 1 )
( 1 0 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 0 5 1 )
( 1 0 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 1 0 1 )
( 1 1 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 1 5 1 )
( 1 1 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 2 0 1 )
( 1 2 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 2 5 1 )
( 1 2 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 3 0 1 )
( 1 3 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 3 5 1 )
( 1 3 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 4 0 1 )
( 1 4 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 4 5 1 )
( 1 4 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 5 0 1 )
( 1 5 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 5 5 1 )
( 1 5 5 1 )
TAAGCACGCGTGGGAAAAGGGCAACGACTGCCCTGCGGGTAGCGCGTACG
TAAGCACGCGTGGGAAAAGGGCAACGACTGCCCTGCGGGTAGCGCGTACG
4 0 1 4 5 0
GGTCTTTTGTAGGCGCGCCGCTGCGCAGGCTGCCGCCAACGCCTCCGTTC
GGTCTTTTGTAGGCGCGCCGCTGCGCAGGCTGCCGCCAACGCCTCCGTTC
4 5 1 5 0 0
CCTGGTGTGCGTCTTCCCGCCTGGTGTCGGTCCGCGTCGGCGACGGCGTA
CCTGGTGTGCGTCTTCCCGCCTGGTGTCGGTCCGCGTCGGCGACGGCGTA
5 0 1 5 5 0
TCCGCTCTCCGAGGATGGCCTCACAAACGAGCTGCTGGACTTCTTCTATT
TCCGCTCTCCGAGGATGGCCTCACAAACGAGCTGCTGGACTTCTTCTATT
5 5 1 6 0 0
ATCTGCAGTTGACCTCCCATGAGGAAGCGGCACGGGAGCGGCTGCTTGGC
ATCTGCAGTTGACCTCCCATGAGGAAGCGGCACGGGAGCGGCTGCTTGGC
6 0 1 6 5 0
TACGTGCAGGCGTGCGTGGCGAAGTTGTGGGGCCCCTGTAAACCGGGGAG
TACGTGCAGGCGTGCGTGGCGAAGTTGTGGGGCCCCTGTAAACCGGGGAG
6 5 1 7 0 0
CGAAGCCGAGGGAACAGCACAGGTGATGCTGTACGGCAGCTACGCTCTAG
CGAAGCCGAGGGAACAGCACAGGTGATGCTGTACGGCAGCTACGCTCTAG
7 0 1 7 5 0
GGCTTTCTCTTCCAAGCAGCGACATTGATCTTGCCCTGACTTTCCCGGCC
GGCnTCTCTTCCAAGCAGCGACATTGATCTTGCCCTGACTTTCCCGGCC
7 5 1 8 0 0
GAGGAGCAGGTGGACGTCGCGACCATTGCAGTTGAGGAAAGGAGTGGGGA
GAGGAGCAGGTGGACGTCGCGACCATTGCAGTTGAGGAAAGGAGTGGGGA
8 0 1 8 5 0
TCGCGCTCTCCTGGCGCCGGCGGTCTCGAAGAAACGCCAGGCGCTGCACC
TCGCGCTCTCCTGGCGCCGGCGGTCTCGAAGAAACGCCAGGCGCTGCACC
8 5 1 9 0 0
TTGAGCGGCTCCACGATCTTGCCGAGCAGCTGCGGAACTCTGCGACGTTT
TTGAGCGGCTCCACGATCTTGCCGAGCAGCTGCGGAACTCTGCGACGTTT
9 0 1 9 5 0
CCCGAGTTGGAGGTAGAGGTGTATGATCAGTGCCGTGTGCCGCGCATTCA 
CCCGAGTTGGAGGTAGAGGTGTATGATCAGTGCCGTGTGCCGCGCATTCA 
9 5 1  1 0 0 0
TCTACGAGACAGGACTTGTGGTGGCGTGTCGTGTGACATCAACAGCTCCT 
TCTACGAGACAGGACTTGTGGTGGCGTGTCGTGTGACATCAACAGCTCCT 
1 0 0 1  1 0 5 0
TCGCCTCAGCACGCATCGCCCGCATCGTGGCGCGGCAGCGGCTATGGCTA 
TCGCCTCAGCACGCATCGCCCGCATCGTGGCGCGGCAGCGGCTATGGCTA 
1 0 5 1  1 1 0 0
CAGGACTCCCCGCTCGCGGCGTTCCTCGTGCGCGTCACCAAGGCAGCCGT 
CAGGACTCCCCGCTCGCGGCGTTCCTCGTGCGCGTCACCAAGGCAGCCGT
1 1 0 1  V  1 1 5 0
GAAGCAGTGAGGCCTCCACGAAGTGTTCTGGGGCGGCGTCGCCTCCACTG
GAAGCAGTGGGGCCTCCACGAAGTGTTCTGGGGCGGCGTCGCCTCCACT
1 1 5 1  1 2 0 0
CGCTGTACTGCCTAGTGCTCCGCTTCCTCGCCCAGATGGAACAGCTTTGC
CGCTGTACTGCCTAGTGCTCCGCTTCCTCGCCCAGATGGAACAGCTTTGC
1 2 0 1 1 2 5 0
CGACACGCGCAGGTGGAGGAGAATTTGTCTCCACCGCGCTACGCGGAGGC
CGACACGCGCAGGTGGAGGAGAATTTGTCTCCACCGCGCTACGCGGAGGC
1 2 5 1 1 3 0 0
CGCCGCCGCGCATGTCGCAACGCAGCTCTCTTCGTTGGCTTGTTCGTCAC
CGCCGCCGCGCATGTCGCAACGCAGCTCTCTTCGTTGGCTTGTTCGTCAC
1 3 0 1 1 3 5 0
CGTTGTCTTCACCACAACTCTCCATGCCACACCCAGCCAACGAGTCTTTC
CGTTGTCTTCACCACAACTCTCCATGCCACACCCAGCCAACGAGTCTTTC
1 3 5 1 1 4 0 0
GCAGCGTTTACCCCAGTTCCAGCCGGCACGGCTTCCACTGCTCGCGGCCT
GCAGCGTTTACCCCAGTTCCAGCCGGCACGGCTTCCACTGCTCGCGGCCT
1 4 0 1 1 4 5 0
CAACAGGCTAAGCGCGGCGGCAGCCGTTCCTTCATATGTACCCAGCTGGG
CAACAGGCTAAGCGCGGCGGCAGCCGTTCCTTCATATGTACCCAGCTGGG
1 4 5 1 1 5 0 0
TTGTGAATAGCAGGAAGCACGACTTGAACAAGTCGTCGTCCTTGTGCGAT
TTGTGAATAGCAGGAAGCACGACTTGAACAAGTCGTCGTCCTTGTGCGAT
1 5 0 1 1 5 5 0
ATGGACAAGAACAGCGCGCTGTGCCCTGTCAGTTTGACCGCTTGCTCCCT
ATGGACAAGAACAGCGCGCTGTGCCCTGTCAGTTTGACCGCTTGCTCCCT
1 5 5 1 1 6 0 0
TTCCGATTGGAGCACGATGAGCAGCACGTGCGACGAGGATAGGGAGGCGG
TTCCGATTGGAGCACGATGAGCAGCACGTGCGACGAGGATAGGGAGGCGG
53
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 6 0 1 )
( 1 6 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 6 5 1 )
( 1 6 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 7 0 1 )
( 1 7 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 7 5 1 )
( 1 7 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 8 0 1 )
( 1 8 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 8 5 1 )
( 1 8 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 9 0 1 )
( 1 9 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 1 9 5 1 )
( 1 9 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 2 0 0 1 )
( 2 0 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 2 0 5 1 )
( 2 0 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 2 1 0 1 )
( 2 1 0 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 2 1 5 1 )
( 2 1 5 1 )
C l o n e d 3 6 . 2 7 5 0  S e q  
L i n J 3 6 . 2 7 5 0
( 2 2 0 1 )
( 2 2 0 1 )
1 6 0 1  1 6 5 0
ACGACGAGGTGGATGGCTACACGCAGGCGGGTCTCACGCGCACCTCCGGC 
ACGACGAGGTGGATGGCTACACGCAGGCGGGTCTCACGCGCACCTCCGGC 
1 6 5 1  1 7 0 0
GCCACCACCACTGCGACTACGCCGATCTCTCGCACCGCGGCGAGCACACC 
GCCACCACCACTGCGACTACGCCGATCTCTCGCACCGCGGCGAGCACACC 
1 7 0 1  1 7 5 0
GATGCCGGCTGCAAGCGAAGCGCATGAGGGAGGCACAGCGACCGCATCGA 
GATGCCGGCTGCAAGCGAAGCGCATGAGGGAGGCACAGCGACCGCATCGA 
1 7 5 1  1 8 0 0
GTGCCTTGGCACCACCAGTGAGCGTCAATTCTGCTGCGCTTCGCGAGGGC 
GTGCCTTGGCACCACCAGTGAGCGTCAATTCTGCTGCGCTTCGCGAGGGC 
1 8 0 1  1 8 5 0
GTGTTTCCCAGTGCGGATGGACTTACTCAGATCGCGCGATCACGGTATGG 
GTGTTTCCCAGTGCGGATGGACTTACTCAGATCGCGCGATCACGGTATGG 
1 8 5 1  Y  1 9 0 0
CGCGTCGCCAGCGCGTCTACTGCTGAAGCTGTGGAAGTTCCTTTCTGCCG 
CGCGTCGCCAGCGCGTCTACTGCTGAAGCTGTGGAAGTTTCTTTCTGCCG 
1 9 0 1  1 9 5 0
ACGCTTTTGCGAACGGGTATCAGGTAGCAGATGCCTTTGGAGATGACGCG 
ACGCTTTTGCGAACGGGTATCAGGTAGCAGATGCCTTTGGAGATGACGCG 
1 9 5 1  2 0 0 0
GTGTGGTGCGACTGCGGCGAGGCGGGCGACTCGGCCGCGCTACCAAAGCA 
GTGTGGTGCGACTGCGGCGAGGCGGGCGACTCGGCCGCGCTACCAAAGCA 
2 0 0 1  2 0 5 0
GCTTCCGCTCATGGCGTCGCTTGAACTGGCCACGATTGCGGGCATGAGCA 
GCTTCCGCTCATGGCGTCGCTTGAACTGGCCACGATTGCGGGCATGAGCA 
2 0 5 1  2 1 0 0
GCGCCGACCTCTCCGCTGCATCTTTTCGGCTTCCTGAGCTACTGGCACTC 
GCGCCGACCTCTCCGCTGCATCTTTTCGGCTTCCTGAGCTACTGGCACTC 
2 1 0 1  2 1 5 0
TTTCGCCACTCGAGCACGTCACTGGAGAGCATGCTCCGGTATCAGCGCTA 
TTTCGCCACTCGAGCACGTCACTGGAGAGCATGCTCCGGTATCAGCGCTA 
2 1 5 1  2 2 0 0
CCCGCGGCGCACCGTGCCAACGATGCTCTCTACCATCTTTGTCGACCCTC 
CCCGCGGCGCACCGTGCCAACGATGCTCTCTACCATCTTTGTCGACCCTC 
2 2 0 1  2 2 2 0  
GGCTGCCGACTAACTCTTGA 
GGCTGCCGACTAACTCTTGA
C LinJ20.1200 (Xylanase) Alignment
C l o n e d
C l o n e d
C l o n e d
C l o n e d
C l o n e d
C l o n e d
C l o n e d
C l o n e d
C l o n e d
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
L i n J 2 0 .1 2 0 0  
L i n f  X y l  S e q
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 1)
( 1)
( 5 1 )
( 5 1 )
( 101 )
( 101 )
( 1 5 1 )
( 1 5 1 )
( 2 0 1 )
( 2 0 1 )
( 2 5 1 )
( 2 5 1 )
( 3 0 1 )
( 3 0 1 )
( 3 5 1 )
( 3 5 1 )
( 4 0 1 )
( 4 0 1 )
( 4 5 1 )
( 4 5 1 )
1 5 0
ATGTCCGCCATCATCATCACACCCGTTGCTCCTGCGACGACGCCGCCCAC 
ATGTCCGCCATCATCATCACACCCGTTGCTCCTGCGACGACGCCGCCCAC
5 1
101
1 5 1
2 0 1
2 5 1
3 0 1
3 5 1
4 0 1
4 5 1
1 0 0
TCGCACCCCTGCAATGCATCTGCATAGCTTTAGCCAACCCACTCAAGCAC
TCGCACCCCTGCAATGCATCTGCATAGCTTTAGCCAACCCACTCAAGCAC
1 5 0
AGCAGCAGCAGCAGCAGCTCCTTTTCCGGCCGCGCTGCGAGGAGGGGGTG
AGCAGCAGCAGCAGCAGCTCCTTTTCCGGCCGCGCTGCGAGGAGGGGGTG
2 0 0
ACATATAGCGAAGACAACAACGGCACCGTGCACTACCGTTTCTACCTTCC
ACATATAGCGAAGACAACAACGGCACCGTGCACTACCGTTTCTACCTTCC
2 5 0
CCATGCCAGCTCTGTTGTTGTCGCTCCTGTGAAGGTTTGCCTGGTGGACA
CCATGCCAGCTCTGTTGTTGTCGCTCCTGTGAAGGTTTGCCTGGTGGACA
3 0 0
GCGATGGTGGCACGGTCCCTGTCGCCTCCATCGGCGCCGCCGCACCCATG
GCGATGGTGGCACGGTCCCTGTCGCCTCCATCGGCGCCGCCGCACCCATG
3 5 0
ACAAAGCACCAAGACGGAGTGTGGGTCGGAACCGTGTCCGCACCAGTCGG
ACAAAGCACCAAGACGGAGTGTGGGTCGGAACCGTGTCCGCACCAGTCGG
4 0 0
ACTGCAGTGTGTCGTCCTCATGGTGGACGGCAACCCTGTGCTCACGCCCC
ACTGCAGTGTGTCGTCCTCATGGTGGACGGCAACCCTGTGCTCACGCCCC
4 5 0
ACCTCAGCATCGGGTGCCTGCATGGGCTCCAGCGGGCAAACTACATCGAT
ACCTCAGCATCGGGTGCCTGCATGGGCTCCAGCGGGCAAACTACATCGAT
5 0 0
GTCCCGCCACCGAACCCAAATCGATGTGTCTACGCCATGCGGCCCTCCGT
GTCCCGCCACCGAACCCAAATCGATGTGTCTACGCCATGCGGCCCTCCGT
54
5 0 1 5 5 0
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 5 0 1 )
( 5 0 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 5 5 1 )
( 5 5 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 6 0 1 )
( 6 0 1 )
C l o n e d
L i n J 2 0 . 1 2  0 0  
L i n f  X y l  S e q
( 6 5 1 )
( 6 5 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 7 0 1 )
( 7 0 1 )
C l o n e d
L i n J 2  0 . 1 2  0 0  
L i n f  X y l  S e q
( 7 5 1 )
( 7 5 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 8 0 1 )
( 8 0 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 8 5 1 )
( 8 5 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 9 0 1 )
( 9 0 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 9 5 1 )
( 9 5 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 1 0 0 1 )
( 1 0 0 1 )
C l o n e d
L i n J 2 0 .1 2 0 0  
L i n f  X y l  S e q
( 1 0 5 1 )
( 1 0 5 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 1 1 0 1 )
( 1 1 0 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 1 1 5 1 )
( 1 1 5 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 1 2 0 1 )
( 1 2 0 1 )
C l o n e d
L i n J 2 0 . 1 2 0 0  
L i n f  X y l  S e q
( 1 2 5 1 )
( 1 2 5 1 )
CGAGCACGGGATGGTGGCCCACAACTACTTGACGTCCTACACAATGGACA
CGAGCACGGGATGGTGGCCCACAACTACTTGACGTCCTACACAATGGACA
5 5 1 6 0 0
CAACCGAGGAAGTTCTTATCTACGTGCCGCCCTCGTATCACAAGGCGAGC
CAACCGAGGAAGTTCTTATCTACGTGCCGCCCTCGTATCACAAGGCGAGC
6 0 1 6 5 0
AGCGCAACACGTCGGTACCCCGTGCTCTACCTCCTGCACGACGACCGCGA
AGCGCAACACGTCGGTACCCCGTGCTCTACCTCCTGCACGACGACCGCGA
6 5 1 7 0 0
GTACCCAATGAACTGCGTACAGCAGGGTAAGGTGAACGTCATCGCCGACA
GTACCCAATGAACTGCGTACAGCAGGGTAAGGTGAACGTCATCGCCGACA
7 0 1 7 5 0
ACCTCATCGCCGACGGCAAGATGACGGAGATGATCATCGTAATGAAGAGT 
ACCTCATCGCCGACGGCAAGATGACGGAGATGATCATCGTAATGAAGAGT 
7 5 1  ▼  8 0 0
AGTGTGAGCGCACGCGCCAATGGTGAATGCATTCCATGCGATGCGGCCAA 
AGTGTGAGCGCACGCACCAATGGTGAATGCATTCCATGCGATGCGGCCAA
8 0 1 8 5 0
GCTCTGCGAAGACCTGACGGAGGACATCATTCCGTACGTCGACAACCACT
GCTCTGCGAAGACCTGACGGAGGACATCATTCCGTACGTCGACAACCACT
8 5 1 9 0 0
ACCGCACCGAGGCAGATCGCGACAACCGCGCCATCGCCGGTCTCTACATG
ACCGCACCGAGGCAGATCGCGACAACCGCGCCATCGCCGGTCTCTACATG
9 0 1 9 5 0
GGCTCCATACAAGCCAGCAGGCTCTGCATAACACGCCACGATCTCTTCGC
GGCTCCATACAAGCCAGCAGGCTCTGCATAACACGCCACGATCTCTTCGC
9 5 1 1 0 0 0
CTACGCCGGCATGTTCTCCGGCTTCCTGAGGAGCAACTGGAACGGCATCA
CTACGCCGGCATGTTCTCCGGCTTCCTGAGGAGCAACTGGAACGGCATCA
1 0 0 1 1 0 5 0
GTACGGACAGCGACCACATCGAAGCCCTCCGCCGCGATCCCGTAGCCTTC
GTACGGACAGCGACCACATCGAAGCCCTCCGCCGCGATCCCGTAGCCTTC
1 0 5 1 1 1 0 0
CAGGCCGCCATGAAAGTGCTCTTCCGTTGCATTGGCGACGACAACACCCA
CAGGCCGCCATGAAAGTGCTCTTCCGTTGCATTGGCGACGACAACACCCA1101 1 1 5 0
CCGCGCCGCGTTCGAGGCGGACGACGCTCTGCTGGCGGAGCTGGGCGTGG
CCGCGCCGCGTTCGAGGCGGACGACGCTCTGCTGGCGGAGCTGGGCGTGG
1 1 5 1 1 2 0 0
CGTGCGAGCGGCGCATCTACGCGGGCTCACATAGCTGGCAGGTATGGCGC
CGTGCGAGCGGCGCATCTACGCGGGCTCACATAGCTGGCAGGTATGGCGC
1 2 0 1 1 2 5 0
CAGGCCGCAGCCGATTTCCTGCCAATGCTATTCAAGGACCTAAGCTTTCT
CAGGCCGCAGCCGATTTCCTGCCAATGCTATTCAAGGACCTAAGCTTTCT
1 2 5 1  1 2 6 3
TCCTCGTCACTGA
TCCTCGTCACTGA
D LinJ36.2050 (SEC14) Alignment
C l o n e d  S E C 14  S e q (1
L i n J 3 6 . 2 0 5 0 (1
C l o n e d  S E C 14  S e q ( 5 1
L i n J 3 6 . 2 0 5 0 ( 5 1
C l o n e d  S E C 14  S e q ( 1 0 1
L i n J 3 6 . 2 0 5 0 ( 1 0 1
C l o n e d  S E C 14  S e q ( 1 5 1
L i n J 3 6 . 2 0 5 0 ( 1 5 1
C l o n e d  S E C 14  S e q ( 2 0 1
L i n J 3 6 . 2 0 5 0 ( 2 0 1
C l o n e d  S E C 14  S e q ( 2 5 1
L i n J 3 6 . 2 0 5 0 ( 2 5 1
1 5 0
ATGGCGGCAACTCATCTTACCTTTGATGATGCGAAGGTGGGCATGCGCGT 
ATGGCGGCAACTCATCTTACCTTTGATGATGCGAAGGTGGGCATGCGCGT
5 1 1 00
CCAGGATTACTGGGGCTGCTGCGGCACGCTACGTTGGATGGGGAAGCTCG
CCAGGATTACTGGGGCTGCTGCGGCACGCTACGTTGGATGGGGAAGCTCG101 1 5 0
AGAAGAACAATTCGCCTAACAAGGAAACAGGCAAGTTCTTCGGTATCGAG
AGAAGAACAATTCGCCTAACAAGGAAACAGGCAAGTTCTTCGGTATCGAG
1 5 1 2 0 0
TACGACGACGAGAGTGACAATCCGCTGCGCAGCAATGGCACGTGGAACGG
TACGACGACGAGAGTGACAATCCGCTGCGCAGCAATGGCACGTGGAACGG
2 0 1 2 5 0
CTGCAAGTACTTTGAGTGCGGGCCGCGTAAGGGCCGTCTTGTGAAGGTAG
CTGCAAGTACTTTGAGTGCGGGCCGCGTAAGGGCCGTCTTGTGAAGGTAG
2 5 1 3 0 0
GCCAAGTTTACGCCGAGATCAACACCGAGCGGGTGGCGATGCTACGGGAG
GCCAAGTTTACGCCGAGATCAACACCGAGCGGGTGGCGATGCTACGGGAG
55
3 0 1 3 5 0
C l o n e d  SE C 1 4  S e q  
L i n J 3 6 . 2 0 5 0
( 3 0 1 )
( 3 0 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 3 5 1 )
( 3 5 1 )
C l o n e d  SE C 1 4  S e q  
L i n J 3 6 . 2 0 5 0
( 4 0 1 )
( 4 0 1 )
C l o n e d  S E C 1 4  S e q  
L i n J 3 6 . 2 0 5 0
( 4 5 1 )
( 4 5 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 5 0 1 )
( 5 0 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 5 5 1 )
( 5 5 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 6 0 1 )
( 6 0 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 6 5 1 )
( 6 5 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 7 0 1 )
( 7 0 1 )
C l o n e d  S E C 1 4  S e q  
L i n J 3 6 . 2 0 5 0
( 7 5 1 )
( 7 5 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 8 0 1 )
( 8 0 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 8 5 1 )
( 8 5 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 9 0 1 )
( 9 0 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 9 5 1 )
( 9 5 1 )
C l o n e d  S E C 14  S e q  
L i n J 3 6 . 2 0 5 0
( 1 0 0 1 )
( 1 0 0 1 )
C l o n e d  S E C 14  S e q  ( 1 0 5 1  
L i n J 3 6 . 2 0 5 0  ( 1 0 5 1
C l o n e d  S E C 14  S e q  ( 1 1 0 1  
L i n J 3 6 . 2 0 5 0  ( 1 1 0 1
C l o n e d  S E C 14  S e q  ( 1 1 5 1  
L i n J 3 6 . 2 0 5 0  ( 1 1 5 1
C l o n e d  S E C 14  S e q  ( 1 2 0 1  
L i n J 3 6 . 2 0 5 0  ( 1 2 0 1
C l o n e d  S E C 14  S e q  ( 1 2 5 1  
L i n J 3 6 . 2 0 5 0  ( 1 2 5 1
CGCTTTGGGGAGCGCGTCGCGACATGGCACGACTTTGAGCTGGTGAAGTT
CGCTTTGGGGAGCGCGTCGCGACATGGCACGACTTTGAGCTGGTGAAGTT
3 5 1
4 0 1
4 5 1
5 0 1
5 5 1
6 0 1
6 5 1
7 0 1
7 5 1
8 0 1
8 5 1
9 0 1
9 5 1
4 0 0
CTGCATTGCGCGACAGTTCGATATGGAAAAGGTCTATGAGATGCTGGAGA
CTGCATTGCGCGACAGTTCGATATGGAAAAGGTCTATGAGATGCTGGAGA
4 5 0
GGCACCTGCAGTGGCGCGGGAGATTCCAGCCGTGCGCCGACGAGTACTTC
GGCACCTGCAGTGGCGCGGGAGATTCCAGCCGTGCGCCGACGAGTACTTC
5 0 0
CCTCAGACGATTCGTGAGGATTACCCGTGCGGCTACACAGGCACTACAGA
CCTCAGACGATTCGTGAGGATTACCCGTGCGGCTACACAGGCACTACAGA
5 5 0
TTACGACGAGAACCTCATTTACTGCGAACGCCCCGGCAATGCTGGCCACT
TTACGACGAGAACCTCATTTACTGCGAACGCCCCGGCAATGCTGGCCACT
6 0 0
GCCAACCGTCCGAGTTTGTGCGCAAGTACACGCTACCGGTAATTGCGCGG
GCCAACCGTCCGAGTTTGTGCGCAAGTACACGCTACCGGTAATTGCGCGG
6 5 0
TGGCACGCGTGCGCTATCGAGATGGGCATTGCGCGCATGCGCGCCACGAA
TGGCACGCGTGCGCTATCGAGATGGGCATTGCGCGCATGCGCGCCACGAA
7 0 0
CTACCGCTCCAAGCGAGTGTGCTGCATTGTGGATCTGTTGAACGTAAAAG
CTACCGCTCCAAGCGAGTGTGCTGCATTGTGGATCTGTTGAACGTAAAAG
7 5 0
CCATGTCGCGTTCGATGATCGGCTTTGCGCAGACGCTGGCGACGGTGGAG
CCATGTCGCGTTCGATGATCGGCTTTGCGCAGACGCTGGCGACGGTGGAG
8 0 0
CAGGACAACTACCCTGAGAACCTAGGGTGCGTCTTTATAGTGAACTGCCC
CAGGACAACTACCCTGAGAACCTAGGGTGCGTCTTTATAGTGAACTGCCC
8 5 0
Ca t g t TTTTCTGCTTTGCCTGGAAGCTGCTGAAGATCTTCATCGACGAAC
CATGTTTTTCTGCTTTGCCTGGAAGCTGCTGAAGATCTTCATCGACGAAC
9 0 0
GCACCAATAAAAAGATTAATTTCTGCGCTCCAAACAAGGCGGTGGAAGCG
GCACCAATAAAAAGATTAATTTCTGCGCTCCAAACAAGGCGGTGGAAGCG
9 5 0
ATGCTGCCGGTGATGCGGAAGGAGGACATACCGAACTTCTGCGGCGGGAC
ATGCTGCCGGTGATGCGGAAGGAGGACATACCGAACTTCTGCGGCGGGAC
1 0 0 0
CAGCAACAAGTGGATGGAAACGGCCAACGGCATCATCGGCTCGACAAACC
CAGCAACAAGTGGATGGAAACGGCCAACGGCATCATCGGCTCGACAAACC
1 0 0 1  1 0 5 0
CGAAAAAGGTCTACAGGGGCGAGGACTACAGCCCGCCCAGCATGACGAGC
CGAAAAAGGTCTACAGGGGCGAGGACTACAGCCCGCCCAGCATGACGAGC
1 0 5 1  1 1 0 0
GAAGAGCTGAATGAGACGCAGTTGCGAGCCGATAGTGAGAGCCCCCACAG
GAAGAGCTGAATGAGACGCAGTTGCGAGCCGATAGTGAGAGCCCCCACAG
1 1 0 1  1 1 5 0
GAGCCTCCGCGAAGGTGAGGCACCGACGACCACGCGCTTCATCGCGCCCG
GAGCCTCCGCGAAGGTGAGGCACCGACGACCACGCGCTTCATCGCGCCCG
1 1 5 1  1 2 0 0
ACGCGGTGTCCTTGAGCTTCACGCCCACCAGTAGCTCCAAATCGCCTGAG
ACGCGGTGTCCTTGAGCTTCACGCCCACCAGTAGCTCCAAATCGCCTGAG
1 2 0 1  1 2 5 0
GAGCCCAAGATGACGTCTGGGGCGCAGAGCAGCAGCGACACGGCAAGCGG
GAGCCCAAGATGACGTCTGGGGCGCAGAGCAGCAGCGACACGGCAAGCGG
1 2 5 1  1 2 8 1
CAAGAAGCGAAAGAACGGTTTGCCGAAGTGA
CAAGAAGCGAAAGAACGGTTTGCCGAAGTGA
Figure 3.1.6: Alignment of the published sequence of genes with the sequence of 
cloned ORFs A) LinJ20.1200 (xylanase); B) LinJ36.2750 (hypothetical); C) 
LinJ28.0330 (hypothetical) and D) LinJ36.2050 (SEC14) on GeneDB compared with 
the sequence of the cloned ORF PCR product. Differences are highlighted by red 
arrowheads.
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3.1.2 Cloning and Sequencing of the Four Genes from L. donovani
In order to confirm that these four genes are could be involved in disease tropism we 
had to confirm that the genes were intact in another species of Leishmania that 
causes the visceral form of the disease. The L. donovani strain BPK206/0 (Clone 
10), is a field isolate from bone marrow biopsy of a 12 year old Nepalese patient in 
2003. These cells were grown up in culture and genomic DNA was isolated for use 
as template in the PCR reactions. L. donovani ORFs for all four genes were 
amplified by PCR, using the same primers used to amplify the ORFs from L. 
infantum (see Table 3.1.1) together with the proof-reading polymerase Phusion 
(NEB). Two independent PCR reactions were canied out for each gene and A- 
overhangs were added to all PCR products. Both independent PCR products for 
each gene were gel-extracted and cloned into T-vectors before being sent sequencing 
in complete, double stranded fomi (the University of Dundee Sequencing Service). 
Note - the data presented in this section was obtained with the help and assistance of 
Elaine Brown, technician in the Mottram lab.
3.1.3 L. donovani ORF Sequence Analysis
Sequences were analysed using ContigExpress (Vector-NTI Advance 10, Invitrogen) 
and contiguous sequences were translated into protein sequences in Vector-NTI. 
These protein sequences were compared with the published L. infantum protein 
sequences using Align-X software (Vector-NTI Advance 10, Invitrogen) and these 
are shown in Figure 3.1.7.
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A L, infantum versus L, donovani 28.0330 Proteins
L . i n f  2 8 . 0 3 3 0 ( 1 )
L . d o n  2 8 . 0 3 3 0 ( 1 )
C o n s e n s u s ( 1 )
L . i n f  2 8 . 0 3 3 0 ( 5 1 )
L . d o n  2 8 . 0 3 3 0 ( 5 1 )
C o n s e n s u s ( 5 1 )
L . i n f  2 8 . 0 3 3 0 ( 1 0 1 )
L . d o n  2 8 . 0 3 3 0 ( 1 0 1 )
C o n s e n s u s ( 1 0 1 )
L . i n f  2 8 . 0 3 3 0 ( 1 5 1 )
L . d o n  2 8 . 0 3 3 0 ( 1 5 1 )
C o n s e n s u s ( 1 5 1 )
L . i n f  2 8 . 0 3 3 0 ( 2 0 1 )
L . d o n  2 8  . 0 3 3 0 ( 2 0 1 )
C o n s e n s u s ( 2 0 1 )
L . i n f  2 8 . 0 3 3 0 ( 2 5 1 )
L . d o n  2 8 . 0 3 3 0 ( 2 5 1 )
C o n s e n s u s ( 2 5 1 )
L . i n f  2 8 . 0 3 3 0 ( 3 0 1 )
L . d o n  2 8 . 0 3 3 0 ( 3 0 1 )
C o n s e n s u s ( 3 0 1 )
L . i n f  2 8 . 0 3 3 0 ( 3 5 1 )
L . d o n  2 8 . 0 3 3 0 ( 3 5 1 )
C o n s e n s u s ( 3 5 1 )
L . i n f  2 8 . 0 3 3 0 ( 4 0 1 )
L . d o n  2 8 . 0 3 3 0 ( 4 0 1 )
C o n s e n s u s ( 4 0 1 )
L . i n f  2 8 . 0 3 3 0 ( 4 5 1 )
L . d o n  2 8  . 0 3 3 0 ( 4 5 1 )
C o n s e n s u s ( 4 5 1 )
1 5 0
M ADVQLSNSSNVKAVYAGHSLSLFM DLRPPAEVLATCSGSW EDLPVTLS  
M ADVQLSNSSNVKAVYAGHSLSLFM DLRPPAEVLATCSGSW EDLPVTLS 
M ADVQLSNSSNVKAVYAGHSLSLFM DLRPPAEVLATCSGSW EDLPVTLS
5 1 1 0 0
VMLRRIHSESETPLSFRCSSSHRLLTYVQCEDGAGGDAVQLGMSGNNLLK  
VMLRRIHSESETPLSFRCSSSHRLLTYVQCEDGAGGDAVQLGMSGNNLLK  
VMLRRIHSESETPLSFRCSSSHRLLTYVQCEDGAGGDAVQLGMSGNNLLK  
1 0 1  1 5 0
VTIDLATFPDRLQRLAAADVAAAEHALLDQSWVIGSRFRLSMQLRTRARA  
VTIDLATFPDRLQRLAAADVAAAEHALLDQSWVIGSRFRLSMQLRTRARA  
VTIDLATFPDRLQRLAAADVAAAEHALLDQSWVIGSRFRLSMQLRTRARA
1 5 1 2 0 0
EWPPLVAPQWSESSDGCLVPTPCSHHMDNHDSAGVMRMREEFAAKGVSAS 
EWPPLVAPQWSESSDGCLVPTPCSHHMGNHDSAGVMRMREEFAAKGVSAS 
EWPPLVAPQWSESSDGCLVPTPCSHHM NHDSAGVMRMREEFAAKGVSAS
2 0 1 2 5 0
PSIV R R N R PLSLY D K SA PR SQ LK G PV Y ID Q ELFPIV R ILFV PQ LY TEA IP
PSIVR R N R PLSLY D K SA PR SQ LK G PV Y ID Q ELFPIV R ILFV PQ LY TEA IP
PSIV R R N R PLSLY D K SA PR SQ LK G PV Y ID Q ELFPIV R ILFV PQ LY TEA IP
2 5 1 3 0 0
TATAVLRSMTVQVGVERCRESRGGKPLRRALRDRSTKDNVAVLDRVPASS
TATAVLRSMTVQVGVERCRESRGGKPLRRALRDRSTKDNVAVLDRVPASS
TATAVLRSMTVQVGVERCRESRGGKPLRRALRDRSTKDNVAVLDRVPASS
3 0 1 3 5 0
STLDEESKALLQPYEAICLAFNAHVRQPSMTSVTAYDVAHARRLW QDYT  
STLDEESKALLQPYEAICLAFNAHVRQPSMTSVTAYDVAHARRLW QDYT  
STLDEESKALLQPYEAICLAFNAHVRQPSMTSVTAYDVAHARRLW QDYT  
3 5 1  4 0 0
FEVMVTAARMKSETVETVQRAIQAYQYESGDADVLGMNLDEAVSSVEERF 
FEVMVTAARMKSETVETVQRAIQAYQYESGDADVLGMNLDEAVSSVEERF 
FEVMVTAARMKSETVETVQRAIQAYQYESGDADVLGMNLDEAVSSVEERF
4 0 1 4 5 0
G YMKDAPS VDLMS FHHWWEAMRACMVADVTS S ALANE LEDELDRYEDRI 
GYMKDAPSVDLMSFHHWWEAMRACMVADVTSSALANELEDELDRYEDRI 
GYMKDAPSVDLMSFHHWWEAMRACMVADVTSSALANELEDELDRYEDRI 
4 5 1
NEILMDM-
NEILMDM-
NEILMDM
B
L . i n f  3 6 .  
L . d o n  3 6 .  
C o n s e n s u s
L . i n f  3 6 .  
L . d o n  3 6 .  
C o n s e n s u s
L . i n f  3 6 .  
L . d o n  3 6 .  
C o n s e n s u s
L . i n f  3 6 .  
L . d o n  3 6 .  
C o n s e n s u s
L . i n f  3 6 .  
L . d o n  3 6 .  
C o n s e n s u s
L . i n f  3 6 .  
L . d o n  3 6 .  
C o n s e n s u s
infantum versus L, donovani 36.2750 Proteins
1 5 0
{ 1 )  M GRIDSSCVAATVTPSKVGASSSCPGTATSTGKIDEPASRAAAPQGRAQR  
( 1 )  M GRIDSSCVAATVTPSKVGASSSCPGTATSTGKIDEPASRAAAPQGRAQR  
( 1 )  M GRIDSSCVAATVTPSKVGASSSCPGTATSTGKIDEPASRAAAPQGRAQR  
5 1  1 0 0
( 5 1 )  CGRARPAQMHNS LSAGMCDNQQQHAAGVWKLIAGPQSASTTPPPLVMGDG 
( 5 1 )  CGRARPAQMHNGLSAGMCDNQQQHAAGWQLIAGPQSASTTPPPLVMGDG 
( 5 1 )  CGRARPAQMHN LSAGMCDNQQQHAAGVW LIAGPQSASTTPPPLVMGDG  
1 0 1  ISO
( 1 0 1 )  TGGEDHAQAAHTGVRWTKH§WEKGNDCPAGSAYGSFVGAPLRRLPPTPPF
( 1 0 1 )  t g g e d h a q a a h a g v r w t k h J w e k g n d c p a g s a y g s f v g a p l r r l p p t p p f
( 1 0 1 )  TGGEDHAQAAH GVRWTKHAWEKGNDCPAGSAYGSFVGAPLRRLPPTPPF
2 7 5 0
2 7 5 0
2 7 5 0
2 7 5 0
2 7 5 0
2 7 5 0
2 7 5 0
2 7 5 0
2 7 5 0
2 7 5 0
2 7 5 0
2 7 5 0
( 1 5 1
( 1 5 1
( 1 5 1
( 2 0 1
(201
( 2 0 1
( 2 5 1
( 2 5 1
( 2 5 1
1 5 1 200
PGVRLPAWCRSASATAYPLSEDGLTNELLDFFYYLQLTSHEEAARERLLG  
PGVRLPAWCRSASATAYPLSEDGLTNELLDFFYYLQLTSHEEAARERLLG  
PGVRLPAWCRSASATAYPLSEDGLTNELLDFFYYLQLTSHEEAARERLLG  
2 0 1  2 5 0
YVQACVAKLWGPCKPGSEAEGTAQVMLYGSYALGLSLPSSDIDLALTFPA  
YVQACVAKIiWGPCKPGSEAEGTAQVMLYGSYALGLSLPSSDIDLALTFPA  
YVQACVAKLWGPCKPGSEAEGTAQVMLYGSYALGLSLPSSDIDLALTFPA
2 5 1 3 0 0
EEQVDVATIAVEERSGDRALLAPAVSKKRQALHLERLHDLAEQLRNSATF
EEQVDVATIAVEERSGDRALLAPAVSKKRQALHLERLHDLAEQLRNSATF
EEQVDVATIAVEERSGDRALLAPAVSKKRQALHLERLHDLAEQLRNSATF
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3 0 1 3 5 0
L.  i n f  3 6 . 2 7 5 0  
L . d o n  3 6 . 2 7 5 0  
C o n s e n s u s
L . i n f  3 6 . 2 7 5 0  
L . d o n  3 6 . 2 7 5 0  
C o n s e n s u s
L . i n f  3 6 . 2 7 5 0  
L . d o n  3 6 . 2 7 5 0  
C o n s e n s u s
L . i n f  3 6 . 2 7 5 0  
L . d o n  3 6 . 2 7 5 0  
C o n s e n s u s
L . i n f  3 6 . 2 7 5 0  
L . d o n  3 6 . 2 7 5 0  
C o n s e n s u s
L . i n f  3 6 . 2 7 5 0  
L . d o n  3 6 . 2 7 5 0  
C o n s e n s u s
L . i n f  3 6 . 2 7 5 0  
L . d o n  3 6 . 2 7 5 0  
C o n s e n s u s
L . i n f  3 6 . 2 7 5 0  
L . d o n  3 6  . 2 7 5 0  
C o n s e n s u s
L.  i n f  3 6 . 2 7 5 0  
L . d o n  3 6 . 2 7 5 0  
C o n s e n s u s
( 3 0 1
( 3 0 1
( 3 0 1
( 3 5 1
( 3 5 1
( 3 5 1
( 4 0 1
( 4 0 1
( 4 0 1
( 4 5 1
( 4 5 1
( 4 5 1
( 5 0 1
( 5 0 1
( 5 0 1
( 5 5 1
( 5 5 1
( 5 5 1
( 6 0 1
( 6 0 1
( 6 0 1
( 6 5 1
( 6 5 1
( 6 5 1
( 7 0 1
( 7 0 1
( 7 0 1
PELEVEVYDQCRVPRIHLRDRTCGGVSCDINSSFASARIARIVARQRLWL
PELEVEVYDQCRVPRIHLRDRTCGGVSCDINSSFASARIARIVARQRLWL
PELEVEVYDQCRVPRIHLRDRTCGGVSCDINSSFASARIARIVARQRLWL
3 5 1 4 0 0
QDSPLAAFLVRVTKAAVKQWGLHEVFWGGVASTALYCLVLRFLAQMEQLC 
QDSPLAAFLVRVTKAAVKQWGLHEVFWGGVASTALYCLVLRFLAQMEQLC 
QDSPLAAFLVRVTKAAVKQWGLHEVFWGGVASTALYCLVLRFLAQMEQLC 
4 0 1  4 5 0
RHAQVEENLSPPRYAEAAAAHVATQLSSLACSSPLSSPQLSM PHPANESF  
RHAQVEENLSPPRYEEAAAAHVATQLSSLACSSPLSSPQLSM PHPANESF  
RHAQVEENLSPPRY EAAAAHVATQLSSLACSSPLSSPQLSM PHPANESF  
4 5 1  5 0 0
AAFTPVPAGTASTARGLNRLSAAAAVPSYVPSW W NSRKHDLNKSSSLCD  
AAFTPVPAGTASTARGLNRLSAAAAVPSYVPSW W NSRKHGLSKSSSLCD  
AAFTPVPAGTASTARGLNRLSAAAAVPSYVPSW W NSRKH L K SSSLCD  
5 0 1  5 5 0
MDKNSALCPVS§TACSLSDWSTMSSTCDEDREADDEVDGYTQAGLTRTSG
m d k n sa l c p v s I t a c s l s d w st m s s t c d e d r e a d d e v d g y t q a g l t r t sg
MDKNSALCPVSLTACSLSDWSTMSSTCDEDREADDEVDGYTQAGLTRTSG 
5 5 1  6 0 0
ATTTATTPISRTAASTPM PAASEAHEGGTATASSALAPPVSVNSAALREG  
ATTTATTPISRTAASTPM PAASEAHEGGTATASSALAPPVSVNSAALREG  
ATTTATTPISRTAASTPM PAASEAHEGGTATASSALAPPVSVNSAALREG  
6 0 1  6 5 0
VFPSADGLTQIARSRYGASPARLLLKLWKFLSADAFANGYQVADAFGDDA  
VF PSADGLTHIARSRYGASPARLLLKLWKFLSADAFANGYQVADAFGDDT 
VFPSADGLT lARSRYGASPARLLLKLWKFLSADAFANGYQVADAFGDD  
6 5 1  7 0 0
v w c d c g e a g d s a a l p k q l p l m a s l e l a t ia g m s s a d l s a a s f r l p e l J a l  
v w c d c g e a g d s a a l p k q l p l m a s l e l a t ia g m s s a d l s a a s f r l p e lHa l
VWCDCGEAGDSAALPKQLPLMASLELATIAGMSSADLSAASFRIiPELLAL 
7 0 1  7 4 0
FRHSSTSLESMLRYQRYPRRTVPTMLSTIFVDPRLPTNS- 
FRHSSTSLENMLRYQRYPRRTVPTMLSTIFVDPRLPTNS- 
FRHSSTSLE MLRYQRYPRRTVPTMLSTIFVDPRLPTNS
L. infantum versus L. donovani 20.1200 (Xylanase) Proteins
1  5 0
M SAIIITPVAPATTPPTRTPAM HLHSFSQPTQAQQQQQQLLFRPRCEEGV  
M SAIIITPAAPATTPPTRTPAM HLHSFSQPTQAQQQQQ-LLFRPRCEEGV  
M S A II I T P  APATTPPTRTPAMHLHSFSQPTQAQQQQQ LLFRPRCEEGV  
5 1  1 0 0
TYSEDNNGTVHYRFYLPHASSVW APVKVCLVDSDGGTVPVASIGAAAPM  
TYSEDNNSTVHYRFYLPHASSVW APVKVCLVDSDGGTVPVASIGAAAPM  
TYSEDNN TVHYRFYLPHASSVW APVKVCLVDSDGGTVPVASIGAAAPM
L . i n f  X y l ( 1 )
L . d o n  X y l ( 1 )
C o n s e n s u s ( 1 )
L . i n f  X y l ( 5 1 )
L . d o n  X y l ( 5 0 )
C o n s e n s u s ( 5 1 )
L . i n f  X y l ( 1 0 1 )
L . d o n  X y l ( 1 0 0 )
C o n s e n s u s ( 1 0 1 )
L . i n f  X y l ( 1 5 1 )
L . d o n  X y l ( 1 5 0 )
C o n s e n s u s ( 1 5 1 )
L . i n f  X y l ( 2 0 1 )
L . d o n  X y l ( 2 0 0 )
C o n s e n s u s ( 2 0 1 )
L . d o n  X y l ( 2 5 0 )
L . i n f  X y l ( 2 5 1 )
C o n s e n s u s ( 2 5 1 )
L . i n f  X y l ( 3 0 1 )
L . d o n  X y l ( 3 0 0 )
C o n s e n s u s ( 3 0 1 )
L . i n f  X y l ( 3 5 1 )
L . d o n  X y l ( 3 5 0 )
C o n s e n s u s ( 3 5 1 )
L . i n f  X y l ( 4 0 1 )
L . d o n  X y l ( 4 0 0 )
C o n s e n s u s ( 4 0 1 )
101 1 5 0
TKHQDGVWVGTVSAPVGLQCWLMVDGNPVLTPHLSIGCLHGLQRANYID
TKHQDGVWVGTVSAPVGLQCWLMVDGNPVLTPHLSIGCLHGLQRANYID
TKHQDGVWVGTVSAPVGLQCWLMVDGNPVLTPHLSIGCLHGLQRANYID
1 5 1 2 0 0
VPPPNPNRCVYAMRPSVEHGMVAHNYLTSYTMDTTEEVLIYVPPSYHKAS
VPPPNPNRCVYAMRPSVEHGMVAHÎJYLTSYTMDTTEEVLIYVPPSYHKAS
VPPPNPNRCVYAMRPSVEHGMVAHNYLTSYTMDTTEEVLIYVPPSYHKAS
2 0 1 2 5 0
SATRRYPVLYLLHDDREYPMNCVQQGKVNVIADNLIADGKMTEMIIVMKS
SATRRYPVLYLLHDDREYPMNCVQQGKVNVIADNLIADGKMTEMIIVMKS
SATRRYPVLYLLHDDREYPMNCVQQGKVNVIADNLIADGKMTEMIIVMKS
2 5 1 3 0 0
SVSARANGECIPCDAAKLCEDLTEDIIPYVDNHYRTEADRDNRAIAGLYM  
SVSARANGECIPCDAAKLCEDLTEDIIPYVDNHYRTEADRDNRAIAGLYM  
SVSARANGECIPCDAAKLCEDLTEDIIPYVDNHYRTEADRDNRAIAGLYM
3 0 1 3 5 0
G SIQASRLCITRHDLFAYAGM FSGFLRSNW NGISTDSDHlEALRRDPVAF  
GSIQASRLCITRHDLFAYAGM FSGFLRSNW NGISTDSDHIEALRRDPVAF  
GSIQASRLCITRHDLFAYAGM FSGFLRSNW NGISTDSDHIEALRRDPVAF
3 5 1 4 0 0
QAAMKVLFRCIGDDNTHRAAFEADDALLAELGVACERRIYAGSHSWQVWR
QAAMKVLFRCIGDDNTHRAAFEADDALLAELGVACERRIYAGSHSWQVWR
QAAMKVLFRCIGDDNTHRAAFEADDALLAELGVACERRIYAGSHSWQVWR
4 0 1  4 2 1
QAAADFLPMLPKDLSFLPRH-
QAAADFLPMLFKDLSFLPRH-
QAAADFLPMLFKDLSFLPRH
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D L. infantum versus L. donovani 36.2050 (SEC 14) Pro teins
L . i n f  S E C 14 (1
L . d o n  S E C 14 (1
C o n s e n s u s (1
L . i n f  S E C 14 ( 5 1
L . d o n  S E C 14 ( 5 1
C o n s e n s u s ( 5 1
L . i n f  S E C 14 ( 1 0 1
L . d o n  S E C 14 ( 1 0 1
C o n s e n s u s ( 1 0 1
L . i n f  S E C 14 ( 1 5 1
L . d o n  S E C 14 ( 1 5 1
C o n s e n s u s ( 1 5 1
L . i n f  S E C 14 ( 2 0 1
L . d o n  S E C 14 ( 2 0 1
C o n s e n s u s ( 2 0 1
L . i n f  S E C 14 ( 2 5 1
L . d o n  S E C 14 ( 2 5 1
C o n s e n s u s ( 2 5 1
L . i n f  S E C 14 ( 3 0 1
L . d o n  S E C 14 ( 3 0 1
C o n s e n s u s ( 3 0 1
L . i n f  S E C 14 ( 3 5 1
L . d o n  S E C 14 ( 3 5 1
C o n s e n s u s ( 3 5 1
L . i n f  S E C 14 ( 4 0 1
L . d o n  S E C 14 ( 4 0 1
C o n s e n s u s ( 4 0 1
1 5 0
MAATHLTFDDAKVGMRVQDYTWGCCGTLRWMGKLEKNNSPNKETGKPFGIE 
MAATHLTFDDAKVGMRVQDYWGCCGTLRWMGKLEKDNSPNKETGKFFGIE 
MAATHLTFDDAKVGMRVQDYWGCCGTLRWMGKLEK NSPNK ETGKFFGIE  
5 1  1 0 0
YDDESDNPLRSNGTWNGCKYFECGPRKGRLVKVGQVYAEINTERVAMLRE 
YDDESDNPLRSNGTWNGRKYFECGPRKGRLVKVGQVYAEINTERVAMLRE 
YDDESDNPLRSNGTWNG KYFECGPRKGRLVKVGQVYAEINTERVAMLRE101 1 5 0
RFGERVATWHDFELVKFCIARQFDMEKVYEMLERHLQWRGRFQPCADEYF 
RFGERVATWHDFELVKFCIARQFDMEKVYEMLERHLQWRGRFQPCVDEYF 
RFGERVATWHDFELVKFCIARQFDMEKVYEMLERHLQWRGRFQPC DEYF
1 5 1 2 0 0
PQTIREDYPCGYTGTTDYDENLIYCERPGNAGHCQPSEFVRKYTLPVIAR
PQTIREDYPCGYTGTTDYDENLIYCERPGNAGHCQPSEFVRKYTLPVIAR
PQTIREDYPCGYTGTTDYDENLIYCERPGNAGHCQPSEFVRKYTLPVIAR
2 0 1 2 5 0
WHACAIEMGIARMRATNYRSKRVCCIVDLLNVKAMSRSMIGFAQTLATVE 
WHACAIEMGIARMRATNYRSKRVCCIVDLLNVKAMSRSMIGFAQTLATVE 
WHACAIEMGIARMRATNYRSKRVCCIVDLLNVKAMSRSMIGFAQTLATVE 
2 5 1  3 0 0
QDNYPENLGCVFIVNCPM FFCFAW KLLKIFIDERTNKKINFCAPNKAVEA  
QDNYPENLGCVFIVNCPM FFCFAW KLLKIFIDERTNKKINFCAPNKAVEA  
QDNYPENLGCVFIVNCPM FFCFAW KLLKIFIDERTNKKINFCAPNKAVEA
3 0 1 3 5 0
MLPVMRKEDIPNFCGGTSNKWMETANGIIGSTNPKKVYRGEDYSPPSMTS 
MLPVMRKEDIPNFCGGTSNKWMETANGIIGSTNPKKVYRGEDYSPPSMKS 
MLPVMRKEDIPNFCGGTSNKWMETANGIIGSTNPKKVYRGEDYSPPSM S 
3 5 1  4 0 0
E ELN ETQ LR A DSESPH R SLREG EA PTTTR FIAPDA V SLSFTPTSSSK SPE  
EELNETQSRADSES PH RSLREGEAPTTTRFIAPDAVS L S F T P T S S  S KS PE 
EELNETQ R AD SESPH R SLR EG EA PTTTR FIA PD A V SLSFTPT SSSK SPE  
4 0 1  4 2 7
EPKMTSGAQSSSDTASGKKRKNGLPK- 
EPKMTSEAQSSSDTASGKKRKNGLPK- 
EPKMTS AQSSSDTASGKKRKNGLPK
F igure  3.1.7: Alignments of the four L. infantum proteins with L. donovani 
orthologues. A) 28.0330 alignment; A single amino acid difference between these 
proteins. B) 36.2750 alignment: 11 amino acid differences between L. infantum and 
L. donovani proteins. C) 20.1220 (xylanase) alignment: 3 amino acid differences. D) 
36.2050 alignment: 6 amino acid differences.
Notably, all four genes are intact in L. donovani, another species that can cause 
visceral Leishmaniasis. This is an important finding, as it adds support to the 
hypothesis that the genes could be involved in influencing disease tropism. The 
primary sequence of each gene is also well conserved between the species.
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3.1.4 Analysis of Equivalent X. major IjOci
Attempts were made to amplify and clone fragments of DNA from L. major, 
equivalent to the positions where the L. m/anfwm-specific genes exist to confirm that 
the L. major sequence held in GeneDB is correct and that the genes have indeed been 
lost rather than simply misassembled. Unfortunately insufficient time was available 
to repeat this and it will be carried out in the future.
3.2 Expression Profile in X. infantum
This work was earned out in collaboration with Dr. Jim Hilley of the University of 
Glasgow. Life cycle specific cDNA was prepare previously by Dr. Jim Hilley and 
sufficient amounts were provided for these experiments. Briefly, procyclic 
promastigotes, metacyclic promastigotes (purified by the peanut agglutination 
method) and amastigotes (extracted and purified from the spleen of an infected 
hamster) were lysed and stored at -80^C in Trizol (Invitrogen). Total RNA was 
extracted from Trizol according to manufacturer's instructions. A quantity of total 
RNA was used to prepare first strand cDNA by Superscriptlll Reverse Transcriptase 
(Invitrogen) according to manufactuier's protocol.
3.2.1 RT-PCR of X. /«yhw^ww-Specific Genes
Nested PCR was used as a way of increasing the specificity and sensitivity of the 
polymerase chain reaction. In the first round of PCR the primer combinations (see 
Table 3.2.1) were used with procyclic promastigote, metacyclic promastigote and 
amastigote first strand cDNA at an annealing temperature of 54°C. The foiward 
primer in all reactions was OL1760, which is a primer that anneals to the splice leader 
sequence of processed mRNA molecules. The reverse primer in all cases was a gene-
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specific primer. This is an added layer of control over non-specific PCR from 
contaminating genomic DNA since the splice leader sequence is not found 
immediately upstream of genes in genomic DNA, only in processed messenger RNA, 
and thus in cDNA. On completion, the first round reactions were diluted ten-fold 
with water and 1 pi of these dilutions was used as a template in second round PCRs 
with different primer combinations (Table 3.2.1), under the same conditions as the 
first round PCR. The forward primer in the second round of PCR was, again 
OL1760, and was used with a gene-specific primer that anneals to a region within the 
amplified fragment in the first round PCR. This method has the added benefit of 
allowing the splice acceptor site to be identified and thus to confirm that the GeneDB 
sequence data held for each gene is annotated con'ectly i.e. that the correct start codon 
has been identified.
Table 3.2.1: Primer combinations used for nested PCR with cDNA to confirm 
expression for the four L. infantum genes and sequences of the primers used.
Gene First round reaction Second round reaction
LinJ28.0330 OL1760 + OL2101 OL1760 + OL2099
LinJ36.2750 OL1760 + OL2105 OL1760 + OL2103
LinJ20.1200
(Xylanase) OL1760 + OL1987 OL1760 + OL2096
LinJ36.2050
(SEC14) OL1760 + OL1985 OL1760 + OL2285
Primer Sequence
OL1760 AACTAACGCTATATAAGTATCAGTTTCTGTACTTTATTG
OL1985 GCAGGATCCTCACTTCGGCAAACCGTTCTTTC
OL1987 GCAGGATCCTCAGTGACGAGGAAGAAAGC
OL2096 GACGTTCACCTTACCCTGCTG
OL2099 CTTCCCGCATCCTCATAACGCC
OL2101 CGTTAAAGGCGAGGCAGATG
OL2103 CTCCCGTGCCGCTTCCTCATG
OL2105 CGATGCGGGCGATGCGTG
OL2285 CAAAGCGCTCCCGTAGCAT
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3.2.2 RT-PCR Results
The reactions were electrophoresed on an agarose gel and DNA fragments in the 
correct size range were detected (Figure 3.2.1). The exact size of the bands is 
unpredictable since the position of the splice acceptor site relative to the start of the 
gene is unknovm. The sizes shown in the schematic of each locus (Figure 3.2.1A-D) 
refer to the size of the fragment from the start of the gene to the reverse primer used 
in the second round of PCR and amplicons should be similar to or larger than these 
since they will correspond to these fragments in addition to any upstream sequence 
between the splice acceptor site and the start codon.
Bands in the appropriate size range and of approximately equal intensity were 
produced from cDNA from each life cycle stage for all genes except LinJ20.1200, 
which appears to be strongly downregulated in amastigote forms (Figure 3.2.1 A-D).
In order to clarify these expression profiles in more detail, it would be necessary to 
carry out Quantitative PCR for each gene, relative to a house-keeping control gene, 
and this will be carried out in the future. Furthermore, the identity of the amplified 
fragments must also be confirmed by cloning and sequencing of the PCR products. 
This was done for LinJ36.2050, but has not yet been done for the other three genes. 
The identity of LinJ36.2050 (SEC 14) has been confirmed in each life cycle stage and 
the splice acceptor and start codon have been identified. The annotated sequence on 
GeneDB has been confirmed (Figui'e 3.2.2).
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LinJ28.0330
OL2099 OL2101 B OL2103 OL2105"I- V
,LinJ36.2750
> 5 7 1 b p
> 5 8 8 b p
Pro Met Ama Pro Met Ama
RT
O.Skb O.Skb
LinJ20.1200
OL2096
OL2117 D
LinJ36.2050)
OL2285 I OL1985
> 6 9 0 b p  
Pro Met Ama
> 4 9 6 b p
Pro Met Ama
RT
- 1  Okb
O.Skb
RT
Figure 3.2.1: RT-PCR Analysis to determine expression profile of the four genes in 
different life cycle stages. Note the exact size of the bands is variable since the 
position of the splice acceptor site relative to the start of the gene is unknown. The 
band sizes shown refer to the size of the fragment from start of the gene to the reverse 
primer. Reaction conditions - Taq DNA polymerase was used with lOx PCR buffer: 
94°C, 5 minutes x 1
94°C, 1 minute
54°C, 4 minutes ^ x 25 cycles
72°C, 1 minute 
72°C, 4 minutes X 1
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A A C TA A C G C TA TA TA A G TA TC A G TTTC TQ TA C TTTA TTG CGCGCGTGTGCGAGTGTC
TGTACG CCATTGAGTGCAGCTGTCGTGCTCGTACTGGGGACGCCCTTGTCCCATTTT
TTCCATATCGCTGCTCTG CCTTTAATTG CAG TG G CG TTG ACTTACAATAAG TG CACA
a g c a c g c a c g c a a a g g a c g t g t c a c t c a c c ^ B g c g g c a a c t c a t c t t a c c t t t g a t
GATGCGAAGGTGGGCATGCGCGTCCAGGATTACTGGGGCTGCTGCGGCACGCTACGT 
TGGATGGGGAAGCTCGAGAAGAACAATTCGCCTAACAAGGAAACAGGCAAGTTCTTC  
GGTATCGAGTACGACGACGAGAGTGACAATCCGCTGCGCAGCAATGGCACGTGGAAC  
GGCTGCAAGTACTTTGAGTGCGGGCCGCGTAAGGGCCGTCTTGTGAAGGTAGGCCAA  
GTTTACGCCGAGATCAACACCGAGCGGGTGGCC
Figure 3.2.2: The sequencing of the RT-PCR fragments for LinJ36.2050. The 
sequences were identical for PCR products for each life cycle stage. The sequence 
highlighted in yellow represents the position of the spliced leader primer, OL1760 
while the sequence highlighted in blue is The start codon of the gene is
highlighted in red This is the first start codon downstream of the spliced
leader sequence.
The presence of transcripts of all genes except LinJ20.1200 (xylanase) in all three life 
cycle stages indicates that these genes are expressed and they no longer need to be 
considered as hypothetical. Rather they are considered to be expressed genes of 
unknown function. Furthermore, the presence of amastigote transcripts means that a 
potential role for encoded proteins in the visceralisation mechanism is still a 
possibility. By contrast, LinJ20.1200 appears to be downregulated in amastigote 
stages meaning that it is less likely to be involved in a visceralisation mechanism. 
The quantification of transcripts at each life cycle stage by real-time quantitative PCR 
analysis will be carried out in the future.
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3.3 Knockout of SEC14 in X. infantum (JPCM5)
3.3.1 Preparation of SEC 14 Knockout Constructs
Leishmania is an organism that is amenable to the removal of genes through targeted 
gene disruption or replacement (Cruz et al., 1991; Cruz et al., 1993). Because 
Leishmania is diploid, there are two allelic copies of each gene and both must be 
replaced by sequential rounds of targeted gene replacement using two antibiotic- 
selectable markers (Figure 3.3.2) as has been done previously within the Mottram lab 
(Flilley et al., 2000; Denise et al., 2006).
rn a n kmk \  SAT DHFRTR J'FUnk / 7
DHFR 6' FR
S'Flank
First Round 
Transfection
SAT KO Cassette BLE KO Cassette
DHFR y  FR r Flank
DHFR S' FR 
S'Flank \  81. DHFRyFR T Flank
BLE KO Cassette V
Second
Round
Transfection
DHFR S'FR 
S' Flank \  SAT DHFR JFR  y  Flank
V SAT KO Cassette
Figure 3.3.2: Overview of the SEC 14 knockout process. The diagram shows the 
first allele being knocked out independently with each KG cassette (SAT and BLE) 
during the first round of transfection. The second round of transfection utilises the 
opposite KG cassette to the first round to replace the remaining copy of the gene.
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In order to knock out both alleles of SEC 14 in L. infantum, two knockout constructs 
were produced. The starting point for these constmcts was pGL1028, a knockout 
construct used previously to knock out a Leishmania major serine peptidase inhibitor 
protein, ISPl in the Mottram lab (unpublished data). The first construct, pGL1534 
(Figure 3.3.3) was made by dropping out the 5’ (iTmdlll and SalX) and 3’ {Xmal and 
Xg/II) flanking regions of pGL1028 in turn and replacing them with 5’ and 3’ 
flanking regions of the L. infantum SEC 14 gene. These flanking regions were 
produced by PCR and were first cloned into a T-vector before being subcloned into 
the knockout construct. Correct insertion of the 5’ and 3’ flanking regions was 
confirmed by PCR and sequencing. The second knockout construct was obtained by 
dropping out the SAT antibiotic resistance marker (using Spel and BamW} and 
replacing it with the BLE antibiotic resistance marker. The BLE gene was obtained 
by digesting an independent knockout construct containing the BLE gene (pGL1422) 
with the same restriction enzymes {Spel and BamClT) and subcloning into pGL1534 
to yield pGL1535 (Figure 3.3.3).
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(firisUll (i)
Unf Seo14 6' Flank
r  Sa n  (628)
DHFRG'FR
PGL1534
7278 bp
DHFR3’ FRBijlll (4476)
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DHFR3’ FR
Unf Sec14 3' Flank
Figure 3.3.3; Schematic of constmcts containing SAT and BLE genes flanked by 
SEC 14 5' and 3' flanking regions. The constmcts pGL1534 (A) and pGL1535 (B) 
were prepared by removing the existing 3' {Xmal and BgHl) and 5' {Hindlll and 
Sail) flanks of a constmct containing the SAT antibiotic resistance gene and 
replacing them with 3'and 5' SEC14 flanking regions. Once obtained, plGL1534 was 
used to obtain pGL1535 by dropping out the antibiotic resistance gene {Spel and 
BamlAV) and replacing it with a BLE-resistance gene from a similar KG construct 
used previously in the Mottram lab (pGL1442). This approach was taken because of 
an internal Xmal site within the BLE gene interfering with the cloning of the V  
flanking sequence.
3.3.2 Preparation for Targeted Gene Replacement 0ÎSEC14
In order to transfect efficiently, approximately 1 Opg of each knockout cassette was 
required. Medium-scale production of pGL1534 and pGL1535 was performed from 
50ml of E. coli overnight cultures using the Qiagen HiSpeed Midi Kit. 40-60pg of 
each plasmid was digested overnight with 15 pi each of Hindlll and Bglll in a 500pl 
reaction volume. Digests were electrophoresed on 0.7% agarose TBE gels. The
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knockout cassette, which was approximately 4.4kb was extracted from the gel using 
multiple Qiagen Gel Extraction Kit columns. The eluted DNA from each column 
was pooled and ethanol-precipitated prior to transfection with wild type L. infantum 
cells.
3.3.2.1 First Round Transfection to Knockout SEC 14 First Allele
The first round of transfection was carried out using the method of Beverley and 
Robinson (2003). Wild type L. infantum JPCM5 cells were transfected with either 
the SAT resistance cassette (from pGL1534) or the BLE resistance cassette (from 
pGL1535) and cultures were split immediately following transfection (SI and S2). 
After several weeks of selection at 75pg/ml nourseothricin, resistant cells were 
growing and dividing well in both cultures, whereas the cells in the control 
transfections had died. The former were grown up and stabilates were made (WCMP 
5599 and WCMP 5600). Additionally, BLE-resistant cells were also recovering 
from the first-round transfections with the BLE cassette, however these succumbed 
to contamination when growing up to make stabilates so were discarded and 
attention was focused on the SAT-resistant cells. Genomic DNA was isolated from 
transfected cells after a single sub-passage and subject to analysis for integration 
using PCR.
3.3.2.2 Check for Correct Integration by PCR
Primers were designed to anneal upstream (OL2300) and downstream (OL2301) of 
the 5' and 3' flanking regions of the Imockout cassettes. These were used with
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primers that hybridise within the knockout cassette itself to check for integration 
(Figure 3.3.4).
PCR using primers OL2301 and OL1031 has produced bands of the expected size 
(approximately 2.Okb) with genomic DNA obtained from both SI and S2 cultures 
(Figure 3.3.4 C, Lanes 2 and 3). The additional bands visible in these reactions are 
presumably due to non-specific primer hybridisation as they are also present in the 
wild type control lane (Figure 3.3.4C, Lane 1). Primers OL2300 and OL1294 also 
gave PCR products of the predicted size of Q.Vkb (Figui'e 3.3.4, Lanes 4 and 5) 
strongly suggesting successful integration.
These putative SEC14ISAT heterozygote cells were used in another round of 
transfection in an attempt to remove the second allele copy of the SEC14 gene.
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OL2300 5' 3’ OL2301
)  %
Unf S e c l4  Gene in Genome
B
OL2300
OL1031
OL1294 0L18
DHFR SA 
5' F lank 5* FR
:> !
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3' FR 3’ F lank OL2301
SEC14 Locus with Integrated SAT KG Cassette 
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Figure 3.3.4: PCR analysis of clones resulting from first round transfection. SAT 
resistant clones were isolated and grown from stationary phase. 2pl of each lysate 
was used as DNA template in 20pl PCR reactions under the conditions described 
below:
95°C, 5 minutes xl
95°C, 1 minute 
54°C, 1 minute 
72°C, 2 minutes 
72°C, lOminutes xl
r  x30
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A) A map of the L. infantum Sec 14 gene in genome locus. B) Map of the L.infantum 
SEC 14 locus showing primer positions used in this PCR. C) Agarose gel showing the 
expected bands. Gel layout is as follows: Lane 1: Wild type OL2301+1031; Lane 2: 
S I-3'Flank region OL2301+1031; Lane 3: S2-3'Flank region OL2301+1031 
(expected size is 2.Okb); Lane 4: Sl-5'Flanlc region OL2300+1294; Lane 5: S2- 
5'Flank region OL2300+1294 (expected size is 0.7kb); Lane M DNA Size markers 
(Ikb DNA Ladder (Invitrogen)). There are some multiple bands which are probably 
due to non-specific primer hybridisation,
3.3.2.3 Second Round Transfection to Completely Remove SEC 14 
The nourseothricin-resistant SEC 14 +/- cells were transfected as before with the BLE 
knockout cassette. Immediately following transfection, the cultures were split 
(2x5ml cultures for each, except control transfections) and recovered overnight in the 
absence of antibiotics. 1ml of each overnight culture was added to 9ml of fresh 
HOMEM plus 10% FCS (plus penicillin/streptomycin) and 10% conditioned medium 
(CM) with 75pg/ml nourseothricin and lOpg/ml phleomycin. The remaining 4ml of 
the overnight cultures was added to 20ml of fresh HOMEM/FCS/CM plus 
antibiotics, as above (Dilution A). 2ml of Dilution A was added to a further 22ml of 
fresh HOMEM/FCS/CM plus antibiotics (Dilution B). Finally 2ml of Dilution B was 
added to another 22ml of fresh HOMEM/FCS/CM + antibiotics. Each dilution was 
plated out on 96 well plates in order to obtain clones.
Three clones were obtained from the plate containing Dilution B (ASEC14-1, 
ASEC14-2 and ASEC14-3). These were grown up in fresh HOMEM plus 10% FCS 
and nourseothricin/phleomycin. These cultures sub-passaged and the remainder was
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used to prepare stabilates (WCMP 5813, 5814 and 5815) and to isolate genomic 
DNA to test for integration by PCR (Figui'e 3.3.5).
PCRs on genomic DNA from wild type and ASEC14-1, 2 and 3 were earned out 
using a range of diagnostic primers to test for the coiTect integration of both KO 
cassettes (see Table 3.3.1 for details of primers as well as predicted fragment sizes). 
These PCRs shown in Figure 3.3.5 (D-K) strongly suggest that both KG cassettes 
have integrated conectly. Reactions D, G and H (Figure 3.3.5) are testing for the 
correct integration of the 5’ portion of the KG cassettes. Reactions E, F, I and J are 
testing integration at the 3’ end of the KG cassettes. Reaction K tests for the 
presence of a complete SEC 14 open reading frame. In most cases, PCR products 
corresponding to the predicted sizes (see Table 3.3.1) are present in all three ASEC14 
clones but absent in the wild type negative eontrol lanes. There are additional bands 
in many of the reactions but these are likely to be non-specific PCR products that are, 
in all cases, also present in the wild type lanes. Integration is best shown by the 
apparent loss of the SEC14 GRFs shovm. in Figui'e 3.5.5K as well as the 5’ 
integration of the SAT cassette (Figure 3.3.5D) and the 5’ integration of the BLE 
cassette (Figure 3.3.50).
It is likely that both copies of SEC14 have been replaced with the two knockout 
cassettes and that SEC 14 has been lost. This can be confirmed by Southern analysis.
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Figure 3.3.5: PCR tests to check for integration of both the SAT and BLE KO 
Cassettes at the SEC14 Locus. A) The schematic of the SEC14 locus with the SAT 
KO Cassette integrated. B) The schematic of the SEC 14 locus with the BLE KO 
Cassette integrated. C) The schematic of the SEC14 locus with SEC14 gene in place. 
The predicted fragment positions are marked by a black arrowhead in each case. 
Predicted fragment sizes and a summary of the above PCR experiments (D-K) are 
shown in Table 3.3.1. Lane W: Wild Type; Lane 1; ASEC14 Clone 1; Lane 2: 
ASEC14 Clone 2; Lane 3: ASEC14 Clone 3
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Table 3.3.1; Test PCRs to check for the integration of both the SAT and BLE KO 
cassettes in all three ASECJ4 clones, compared with wild type.
Figure
3:3.5
Ref
Primer Pair KO Cassette 
Tested
Predieted 
Fragment Size 
(kb)
Positive ASEC14 
Clones
D OL2300
0L17
SAT 5’ 1.7 1, 2 and 3
E OL230I
0L18
SAT 3’ 2.5 1, 2 and 3
F OL2301
OL1031
SAT 3’ 2.5 1,2 and 3
G OL2300
O L ll
BLE 5’ 1.7 1,2 and 3
H OL2300
OL1290
BLE 5’ 2.0 Possibly L 2 and 
3
I OL2301
0L12
BLE 3’ 2.5 2 and 3
J OL2301
OL512
BLE 3’ 2.8 None
K OL1984
OL1985
WT SEC14 ORE 1.3 WT only
3.3.3.2 Southern blot analysis of SEC 14 mutants
In order to confirm the PCR data, Southern analysis was used to examine the SECI4 
locus to confirm integration of the knockout cassettes and the subsequent loss of the 
SEC14 ORE. The sequence of the SEC14 locus (the ORE and lOkb each of 5’ and 3' 
flanking sequence) was obtained from the L. infantum database in GeneDB 
(http://www.genedb.org/genedb/linfantum/) and used in Vector NTi software 
(Invitrogen) to generate a restriction map of the locus (Figure 3.3.6).
Genomic DNA was extracted from a 30ml culture of stationary-phase wild type L. 
infantum (JPCM5) and the three putative ASEC14 clones. Genomic DNA (3pg per 
digest) was digested overnight with either Xhol or Hindlll. Digests were run out on 
a medium sized 0.7% agarose TBE gel and the gel was treated and blotted overnight 
by capillary transfer.
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The blot was blocked and probed using a radiolabeled fragment corresponding to the 
SEC 14 y  flanking region (Figure 3.3.6A). The blot was exposed to autoradiography 
film overnight and then for 3 days and is shown in Figure 3.3.6B.
The predicted fi’agment sizes for the various alleles are listed in Table 3.3.2.
Table 3.3.2: Predicted and Approximate Observed Fragment Size for Each Allele
Digest
H ind lll Xhol
Allele Predicted Observed Predicted Observed
Wild Type 3.2kb ~ 3.2kb 2.3kb ~2.3kb
SAT KG 4.8kb ~ 4.8kb 3.4kb ~ 3.4kb
BLE KG 4.7kb ~4.8kb 3.3kb -3 3 k b
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Hindlll (4502)
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W 1 2 3
Xho\
X h o l(2099) 
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Hindlll (1376)
2.3kb
Ur# S«c14 Cyto*olfc F»c«or (Putattva)
Xhol 14360)
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kb W  1 2
Figure 3.3.6: Southern analysis of ASEC14 mutants. The schematic structure of the 
SEC 14 locus is containing the wild type gene showing the fragments expected when 
digesting with Hindlll (A) and Xhol (B). The fragment sizes with the SAT KO 
cassette integrated correctly is also shown with predicted fragment sizes for Hindlll 
(C) and Xhol (D). Genomic DNA from wild type L. infantum as well as each of the 
three ASEC14 clones was digested with Hindlll or Xhol . Digests were run out on 
0.7% agarose gels and the DNA was blotted onto Hibond-N membrane. A probe 
corresponding to part of the 3’ flanking region (indicated by double headed red arrow
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in A-D) was radiolabeled with 32P-CTP (Amersham) and the probe was hybridised 
with the membrane overnight at 65^C. Blots were washed with high stringency 
washing solution (O.lx SSC, 0.1% SDS) at 65°C then exposed to autoradiography 
film for 3 days. The Hindlll and the Xhol Southern blots are shown in (E) and (F) 
respectively. The arrangement of lanes is the same for each blot:
Lane W: Wild type gDNA 
Lane 1: Clone 1 gDNA 
Lane 2: Clone2 gDNA 
Lane 3: Clone3 gDNA
The observed band sizes appear to match the predicted fragment sizes. The signal in 
the Clone 3 lane is very weak, although it was visible on the original autoradiogram. 
This is likely to be due to uneven loading of DNA between lanes as well as loss of 
resolution during image scanning. There is only a small difference in size between 
the SAT and BLE cassettes meaning that the bands are unlikely to be distinguishable 
from one another with these combinations of probe and restriction enzymes, hence 
the observed single band. When taken together with the PCR data above, this 
strongly indicates that the knockout cassettes have integrated at the correct position 
and successfully replaced both copies of SEC 14, which has been lost from the three 
ASEC14 clones.
Due to the well-documented plasticity of the Leishmania genome (Cruz et al., 1993; 
Smith et al., 2007) it is necessary to confirm that the ploidy of the thiee ASEC14 
clones is unaffected. This was done using Flow Cytometry (see Section 3.3.3.3).
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3.3.33 DNA Content Analysis of ASEC14 Mutants by FACS
Mid log-phase cells were methanol-fixed and stained with propidium iodide for 
FACS analysis to determine the DNA content of all three L. infantum ASEC14 clones 
with respect to the DNA content of wild type L. infantum. The peaks corresponding 
to cells in G1 and G2 phase of the cell cycle in the mutant cells occur in the same 
position as those of wild type cells indicating that the DNA content of the mutants is 
normal (Figure 3.3.7). This suggests that SEC14 is not an essential gene to 
promastigotes grown in culture.
G1
G2
Figure 3.3.7: Analysis of the DNA content of wild type and ASEC14 cells by Flow 
Cytometry. Wild type L. infantum cells together with 3 ASECI4 knockout clones 
were propidium iodide stained and analysed by Flow Cytometry to determine if there 
were any abnormalities in the DNA content.
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The SEC14 laiockout clones were then analysed further to determine if loss of 
SEC 14 results in a detectable phenotype in terms of growth and in vitro infectivity to 
macrophages.
3.4 Phenotype analysis 0ÏSEC14 Null Mutants
3.4.1 Growth Curves
To detennine the growth rate of ASEC14 promastigotes in culture, four 10ml 
replicate cultures were set up at 5 x 10  ^cells/ml for wild type and three clones (16 
cultures in total). Cells were prepared for counting at 24h intervals for seven days by 
formaldehyde fixation and were counted using a haemocytometer. One observation 
was that lSSEC14-\ consistently took longer to recover from the initial lag-phase but 
did recover and reached stationary phase at about the same time as the other 
knockout clones as well as wild type L. infantum. Overall, no significant variation 
between wild type and three mutants was noted (Figure 3.4.1).
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Figure 3.4.1: Growth curves for ASEC14 clones 1-3 compared with wild type L. 
infantum. All growth cultures were set up at a density of 5 x 10  ^cells/ml. Cells were 
incubated at 25°C and counted at 24 hour intervals for seven days.
3.4.2 In Vitro Macrophage Infections with ASEC14 Promastigotes
Intra-peritoneal macrophages were harvested from a single immunocompromised 
CDl/ICRl mouse. These were counted and resuspended at a density of 5 x 10^  
cells/ml in RPMI medium + 10% PCS and allowed to adhere for 24 hours to the 
surface of 16-well chamber slides with covers (Labtek). After adhering, 
macrophages were washed in fresh RPMI/FCS and exposed to stationary phase wild 
type L. infantum and ASEC14 1-3 (four replicate wells for each cell line). After 24 
hours, slides were washed with RPMI to remove free promastigotes and infection 
was allowed to proceed for 7 days. Three timepoints were taken (1 day, 4 days and 7
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days post infection) at which time, macrophages and promastigotes were methanol- 
fixed. Once all timepoints had been taken and all wells were methanol-fixed, slides 
were stained with Giemsa for 10 minutes before rinsing with distilled water. 100 
macrophages were counted for each well and the number of infected macrophages 
was recorded (Figure 3.4.2). The infection rate at day 1 and day 4 for wild type cells 
remained fairly constant at approximately 10% of macrophages infected with one or 
more L. infantum cells per macrophage. Giemsa staining of the day 7 samples 
revealed extensive damage to macrophages, which is likely to have been inflicted 
during preparation of the slides and were unfortunately too degraded to get 
meaningful data. This experiment will be repeated at a later date.
In Vitro Macrophage Infection
60
m m m m ^
£  40
m m m
■ Wild Type
□ K01
□  K02
■  KO 3
Days Post-Infection
Figure 3.4.2: In vitro macrophage infection data. Intra-peritoneal macrophages 
from CDl/ICRl mouse were infected with wild type and ASEC14 1-3 clones at a 
ratio of 8 promastigotes toi macrophage as described in the text. Macrophages were 
fixed at 1 day, 4 days and 7 days post-infection and Giemsa-stained to allow
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visualisation of infected macrophages. Note that the Day 4 time point for K03 was 
not suitable for counting due to sample degradation and is not included in this 
Figure. Day 7 timepoints were also degraded and could not be accurately counted. 
Error bars are +/- standard deviations.
The infection rate at day 1 and day 4 for wild type cells remained fairly constant at 
approximately 10% of macrophages infected with one or more L. infantum cells per 
macrophage. The apparent reduction of the rate of macrophage infectivity by clone 
2 falls within experimental error making it impossible to draw conclusions. Giemsa 
staining of the day 7 samples revealed extensive damage to macrophages, which is 
likely to have been inflicted during preparation of the slides and were unfortunately 
too degraded to get meaningful data. This experiment will be repeated at a later 
date. Alternative sources for macrophages will also be used in future experiments as 
mo se peritoneal exudate-derived macrophages may not be the best source 
visceralising species of Leishmania.
3.4.3 Hamster Infections
The next stage was to test whether ASEC14 promastigotes are capable of establishing 
infection in animals. The animal model for visceral infection is the Golden Syrian 
hamster. Three L. infantum cell lines, wild type and ASEC14 clones 2 and 3 were 
each inoculated into two hamsters. Inoculations were carried out by intraperitoneal 
(i.p.) injection with 400pl of stationary phase promastigotes in PBS at a density of 
2.5 X 10  ^ cells/ml (a total of 10  ^ stationary phase promastigotes per hamster). 
Spleens were extracted from one hamster for each cell line at 4 months post-injection 
and a small section of tissue from each was transferred to fresh HOMEM + 20%
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FCS in order to determine if amastigotes could be recovered and differentiated to 
promastigotes. At 2 weeks post inoculation of the HOMEM culture medium, no 
promastigotes could be detected, however, these cultures will be incubated for longer 
to determine if promastigotes can eventually be recovered. At the time of writing, 
spleens of hamsters infected with wild type L. infantum and àSEC14-1> (also at 4 
months post-inoculation) were extracted and used to inoculate culture medium as 
before. It remains to be seen whether promastigotes can be recovered from these 
tissue samples.
3.4.4 Mice Infections
In order to test the vimlence of one of the ASEC14 clones (ASEC14-1) and to see if 
the loss of SEC 14 results in cutaneous infection rather than visceral infection, six 
mice were inoculated in the right footpad with 20|il of stationary phase lsSEC14~l 
promastigotes at a density of 2.5 xlO^ ml of stationary phase promastigotes (a total 
of 5x10^ promastigotes per footpad). As a negative control for infection, a further 
six mice were footpad-inoculated with 40pi stationary phase wild type L. infantum at 
density of 2.5x10^ cells/ml. At 5 months post-inoculation, no lesions were observed 
at the inoculation site for either cell line in any of the mice and the experiment was 
terminated.
Loss of SEC14 does not appear to cause a switch in tropism from visceral to 
cutaneous disease.
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CHAPTER 4 - DISCUSSION
The aim of this project was to begin the analysis of four genes that are specific to L. 
infantum and that may have a role in the visceralisation mechanism. Analysis of the 
published sequence has revealed little about a potential role for LinJ28.0330, 
however the other hypothetical protein, LinJ36.2750 has a domain that has homology 
to the S. cerevisiae topoisomerase related function 4 protein (Trf4p). This protein is 
a component of the yeast nuclear exosome complex. The protein has been shown to 
have poly(A) RNA polymerase activity and is involved in the polyadenylation of 
tRNA and rRNA as well as small nucleolar RNAs (snoRNAs), which facilitates their 
degradation by the nuclear exosome complex (Haracska et al., 2005; LaCava et al.,
2005). Reciprocal BLASTp searches of the L. infantum predicted proteins database 
have revealed several Leishmania genes that encode proteins with TRF4 domains 
and LinJ36.2750 is the third highest hit. The first two predicted proteins, 
LinJ07.0750 and LinJ26.0480 (known as LinJ07_V3.0780 and LinJ26_V3.0480 
respectively in the most recent release of the L. infantum database in GeneDB 
(www.genedb.org), are also found in L. major and L. braziliensis.
Analysis of the amino acid sequence of LinJ36.2050 (SEC 14) has shown a domain 
structure quite unlike any other known SEC 14-like protein identified to date. Instead 
of the N-terminal CRAL TRIO domain, which is an extension of the lipid binding 
SEC 14 domain found in yeast Secl4p (Saito et al., 2007), the L. infantum protein has 
a CAP GLY domain (Cytoskeleton Associated Protein). This domain has been 
identified and stmcturally characterised in proteins such as the mammalian 
cytoplasmic linker protein 170 (CLIP-170), where it mediates binding at the + end of
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the microtubule (the end that is moving away from the microtubule organising centre 
(MTOC) (Mishima et al., 2007). This combination of CAP GLY and SEC 14 lipid 
binding domains might indicate a potential role in trafficking of vesicles within the 
cell. To date over 500 SEC 14-like proteins all within eukaryotic species have been 
identified with roles in processes such as vesicle trafficking and phospholipid 
metabolism (Mousley et al., 2007; Phillips et al., 2006). Only two proteins with the 
CAP GLY domain and the SEC 14 domain have been identified to date: LinJ36.2050 
and the orthologue of this gene in Trypanosoma cruzi. The reason why T. cruzi 
would require this protein is unclear, however it is important to note that T. cruzi also 
has an intracellular stage to its life cycle within mammalian hosts, so perhaps this is 
where the influence on disease tropism is taking place.
In order to determine if the GeneDB sequences were cori'ect, the four genes were 
amplified by PCR, cloned and sequenced. The sequences for all four genes were a 
good match for the published sequences in GeneDB and where differences were 
observed, these could be explained by PCR-introduced mutations. To confirm this, 
an independent PCR clone for each ORF that had sequence variation, namely 
LinJ36.2750 and LinJ20.1200, should be sequenced and this will be carried out as 
part of follow up work on this project. These differences result in amino acid 
changes but not in frameshifts or the introduction of stop codons. If these genes 
were to have a potential role in the visceralisation mechanism, one would predict that 
the genes will be intact in other Leishmania species that cause VL. The four' genes 
were therefore amplified and cloned from a strain of L. donovani that was available 
within the lab, BPK206/0. Cloning and analysis of two independent PCR products 
for each gene has revealed that the genes are indeed intact in L. donovani and that
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they are well consei-ved between the species, indicating that they are likely have a 
biologically-relevant function to both species. It remains to be determined if this 
function forais part of the visceralisation mechanism. It is a formal albeit unlikely 
possibility that although these genes have been reported as pseudogenes or indeed 
missing for L. major genome project strain (MHOM/IL/80/Friedlin) that they may be 
intact in other strains of L. major, which would almost certainly rule out a role in 
visceralisation. Future work will involve analysing the loci of these genes in another 
strain of L, major that is available within the Mottram lab (MRHO/IR/75/ER, a strain 
isolated in Iran and chosen by the WHO as the vaccine challenge strain (Davoudi et 
al., 2005)) to confirm or otherwise, that these genes are also pseudogenes in L. major 
IR-75.
All four genes were shown to be expressed in procyclic and metacyclic promastigote 
stages of the life cycle and only LinJ20.1200 (endo-1,4-(3-xylanase precursor) 
appeared to be dowm’egulated in the amastigote stage. This strongly suggests that 
the requirement for an enzyme capable of degrading components of plant cell walls 
is not required by amastigote forms of L. infantum. This is in keeping with the 
hypothesis that this protein would most likely be required in the insect 
(promastigote) stages of the life cycle since it has been documented that the insect 
host, the female sand fly feeds on plant material between blood meals (Brito et al.,
2006). In this respect it is noteworthy that a number genes encoding enzymes 
suitable for metabolising plant sugars have been identified in the Leishmania 
genomes, but are absent in T. brucei (Opperdoes and Coombs, 2007). This correlates 
with the feeding habits of tsetse, which are blood-sucking insects and do not feed on 
plant material. Whether the parasite utilises LinJ20.1200 for nutrition or for some
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other purpose within the sand fly midgut and/or mouthparts remains to be 
determined.
LinJ36.2050 (SEC14) was confirmed as being expressed in the amastigote life cycle 
stage and was therefore selected as the main focus of the remainder of the project. 
Leishmania infantum ASEC14 mutants were generated by two rounds of homologous 
recombination with drug selectable markers using established procedures (Hilley et 
al., 2000; Denise et al., 2006). As SEC14 null mutants could be isolated, this 
indicates that SEC 14 is not essential to promastigotes growing in culture and indeed, 
growth curves revealed that cells are capable of growing and dividing in culture at a 
similar rate to wild type L. infantum. Furthermore, in vitro mouse peritoneal 
macrophage infections with all three ASEC14 clones together with wild type has 
shown that mutant promastigotes can infect macrophages to about the same degree 
as wild type cells. This experiment must be repeated in order to determine if 
ASEC14 cells can persist and proliferate as amastigotes in macrophages. The 
infection rate at day 1 and day 4 for wild type cells remained fairly constant at 
approximately 10% of macrophages infected with one or more L. infantum cells per 
macrophage. Any variation in this, for example, the apparent reduction in infection 
rates of clones 2 and 3, falls within the experimental enur range and are therefore 
inconclusive. The extensive damage to macrophages of the day 7 timepoint means 
that it is not known whether amastigotes can persist and proliferate. This experiment 
will be repeated in the future, probably using alternative sources for macrophages. 
BALB/c mouse bone-marrow macrophages have been used successfully in L. 
infantum in vitro infection studies by collaborators (D.F. Smith, personal 
commimication).
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àSEC14-\ and wild type stationary phase promastigotes were inoculated into the 
footpads of 6 BALB/c mice each. No sign of cutaneous infection could be seen in 
any of these mice after 5 months, suggesting that the loss of SEC 14 does not cause a 
switch in tropism from visceral to cutaneous disease. BALB/c mice are not good 
mammalian hosts for L. infantum^ so it is unsurprising that no infection was observed 
with either wild type or L^EC14-\ parasites. Whilst dogs provide an excellent 
experimental model for visceral disease with the genome strain JPC L. infantum 
(Foot et al., 2005), hamsters can also provide a suitable infection model (Denise 
Hubert et al., 2006). As it was not possible to carry out experiments on dogs in 
Glasgow, the ASEC14-2 and 3 mutants were each inoculated into 2 hamsters. One 
hamster containing ASEC14-2 was culled and a segment of spleen was removed to 
inoculate promastigote growth medium. At the time of writing (2 weeks after culture 
inoculation), no promastigotes could be detected in the growth medium, however it 
has been found within this laboratory that differentiation of L. infantum from spleen 
segments, can often take several weeks. Spleen samples have now been extracted 
from hamsters infected with wild type L. infantum and ASEC14-3 and transferred to 
growth medium. It remains to be seen whether promastigotes can be recovered from 
these tissue samples and until then, nothing can be concluded about the ability of 
ASEC14 cells to infect hamsters.
To date, only one L. donovani—specific protein has been implicated in disease 
tropism -  the A2 protein (Charest and Matlashewski, 1994). It has been shown that 
heterologous expression of the A2 gene in L. major, which lacks a functional copy of 
this gene, leads to an increased ability of L. major to survive within the spleen of
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BALB/c mice as well as reduced ability to establish cutaneous infection (Zhang and 
Matlashewski, 2001; Zhang et al., 2003). This body of work indicates that disease 
tropism in Leishmania, although likely to involve numerous different proteins, can be 
influenced by the presence or absence of a single gene and is validation of the 
approach taken in this project. Similar to the A2 gene experiments, heterologous 
expression of the four L. infantum-specific genes in L. major will be carried out in 
future work.
By contrast with yeast Secl4p, which is essential, L. infantum LinJ36.2050 is not 
essential which raises the possibility that the encoded protein is not the true 
orthologue of the yeast protein. This is in agreement with unusual domain structure 
observed in L. infantum SEC 14 and the discovery that there is another protein with a 
slightly higher degree of homology, as well as a more similar domain structure to 
yeast Secl4p (LinJ35.3630), that is also found in both L. major and L. braziliensis 
(LmjF35.3560 and LbrM32_V2.1420 respectively, see above). Yeast Secl4p is 
involved in the budding of secretory vesicles from the trans-Golgi network (TGN) to 
the plasma membrane (Bankaitis et al., 1989). One might predict that a protein 
involved in such a central process as secretory vesicle budding would be more likely 
to exist in all species of Leishmania rather than just L. infantum. It is possible that L. 
infantum has a subclass of LinJ36.2050-containing secretory vesicles that contain L. 
infantum specific virulence factors that influence disease progression.
Further experiments that will be carried out in time will involve targeted gene 
replacement of the two hypothetical genes, LinJ28.0330 and LinJ36.2750 and 
subsequent phenotype analysis of mutant lines. These genes as well as LinJ36.2050
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will also be expressed heterologously in L. major to determine if the disease tropism 
of that species (CL) can be influenced. More detailed analysis of the role of 
LinJ36.2050 is ongoing and involves the localisation of the protein in L. infantum 
promastigotes by expression of tagged versions of the protein, as well as expression 
of recombinant protein for antibody production. The original S. cerevisiae 
temperature sensitive mutant has been provided by Professor Vytas Bankaitis of the 
University of North Carolina at Chapel Hill and yeast complementation studies will 
be used to determine if LinJ36.2050 and/or the putative true orthologue of Secl4p, 
LinJ35.3630 can rescue the yeast mutant phenotype.
While host immunity undoubtedly plays a part in tropism, it is likely that the 
parasites themselves have some form of control over disease progression. The 
ongoing project of which the presented work is a small part, aims to determine 
whether parasite factors indeed contribute to the disease tropism of L. infantum and 
to begin to umuvel the roles of these species-specific genes.
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